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A B S T R A C T
Background
Randomised trials (also referred to as ‘randomised controlled trials’ or ‘trials’) are the optimal way to minimise bias in evaluating the e$ects
of competing treatments, therapies and innovations in health care. It is important to achieve the required sample size for a trial, otherwise
trialists may not be able to draw conclusive results leading to research waste and raising ethical questions about trial participation. The
reasons why potential participants may accept or decline participation are multifaceted. Yet, the evidence of e$ectiveness of interventions
to improve recruitment to trials is not substantial and fails to recognise these individual decision-making processes. It is important to
synthesise the experiences and perceptions of those invited to participate in randomised trials to better inform recruitment strategies.
Objectives
To explore potential trial participants’ views and experiences of the recruitment process for participation. The specific objectives are
to describe potential participants’ perceptions and experiences of accepting or declining to participate in trials, to explore barriers and
facilitators to trial participation, and to explore to what extent barriers and facilitators identified are addressed by strategies to improve
recruitment evaluated in previous reviews of the e$ects of interventions including a Cochrane Methodology Review.
Search methods
We searched the Cochrane Library, Medline, Embase, CINAHL, Epistemonikos, LILACS, PsycINFO, ORRCA, and grey literature sources. We
ran the most recent set of searches for which the results were incorporated into the review in July 2017.
Selection criteria
We included qualitative and mixed-methods studies (with an identifiable qualitative component) that explored potential trial participants’
experiences and perceptions of being invited to participate in a trial. We excluded studies that focused only on recruiters’ perspectives,
and trials solely involving children under 18 years, or adults who were assessed as having impaired mental capacity.
Data collection and analysis
Five review authors independently assessed the titles, abstracts and full texts identified by the search. We used the CART (completeness,
accuracy, relevance, timeliness) criteria to exclude studies that had limited focus on the phenomenon of interest. We used QSR NVivo to
extract and manage the data. We assessed methodological limitations using the Critical Skills Appraisal Programme (CASP) tool. We used
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thematic synthesis to analyse and synthesise the evidence. This provided analytical themes and a conceptual model. We used the GRADE-
CERQual (Confidence in the Evidence from Reviews of Qualitative research) approach to assess our confidence in each finding. Our findings
were integrated with two previous intervention e$ectiveness reviews by juxtaposing the quantitative and qualitative findings in a matrix.
Main results
We included 29 studies (published in 30 papers) in our synthesis. Twenty-two key findings were produced under three broad themes
(with six subthemes) to capture the experience of being invited to participate in a trial and making the decision whether to participate.
Most of these findings had moderate to high confidence. We identified factors from the trial itself that influenced participation. These
included how trial information was communicated, and elements of the trial such as the time commitment that might be considered
burdensome. The second theme related to personal factors such as how other people can influence the individual’s decision; and how a
personal understanding of potential harms and benefits could impact on the decision. Finally, the potential benefits of participation were
found to be key to the decision to participate, namely personal benefits such as access to new treatments, but also the chance to make
a di$erence and help others. The conceptual model we developed presents the decision-making process as a gauge and the factors that
influence whether the person will, or will not, take part.
Authors' conclusions
This qualitative evidence synthesis has provided comprehensive insight into the complexity of factors that influence a person's decision
whether to participate in a trial. We developed key questions that trialists can ask when developing their recruitment strategy. In addition,
our conceptual model emphasises the need for participant-centred approaches to recruitment. We demonstrated moderate to high level
confidence in our findings, which in some way can be attributed to the large volume of highly relevant studies in this field. We recommend
that these insights be used to direct or influence or underpin future recruitment strategies that are developed in a participant-driven way
that ultimately improves trial conduct and reduces research waste.
P L A I N   L A N G U A G E   S U M M A R Y
What factors influence a person's decision whether or not to take part in a randomised trial?
What is the aim of this review?
Randomised trials are needed for understanding if and how di$erent healthcare interventions (such as medicines, types of surgeries, health
promotion activities, etc.) work or not. Getting people to take part in trials can be di$icult and if not enough people participate, then the
trial will not provide the information that it set out to. By learning more about what influences a person’s decision to take part in a trial,
we can provide advice on how best to include people in trials.
To answer this question, we brought together the findings of 29 studies reporting the views and experiences of people who had been invited
to take part in a randomised trial.
Key messages
Several factors influence a person’s decision to take part in a trial including: how the trial is set up and communicated; people’s own
personal circumstances; and the potential benefits of participation. It is important that those working in trials take these into account when
inviting people to participate. It is important that this is done in a manner that recognises that all people are di$erent and may consider
the trial in a di$erent way.
What was studied in the review?
We searched for studies that examined the views of those who had been invited to take part in a randomised trial. We included studies
with people who had agreed to take part as well as those who had decided not to take part. We included studies published since the start
of the year 2000.
Our searches identified 29 studies (published in 30 papers) to include in this review. Sixteen studies were conducted in the UK, six in other
European countries, three in the USA, one each in Canada, Australia, New Zealand and Tanzania. The trials that people had been invited
to take part in were for cancer (n = 7); pregnancy and childbirth (n = 5); medicine and surgery (n = 11); mental health (n = 2); and health
promotion (n = 4).
Our review pointed to three main factors that influenced whether potential participants agreed to take part in a trial or not. We judged the
following findings to have moderate to high confidence.
What are the main findings?
People preferred to be invited in a face-to-face setting, with information communicated clearly. Written information was also useful. The
timing of the invitation is important because potential participants could find it di$icult to recognise the care they usually receive and care
that would be provided as part of the trial.
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Commitment to the trial can make people worried about participating. Some believed that extra appointments and the time involved
would be a burden. Sometimes people are o$ered money as a way to recompense them for their commitment. Payment was welcomed
by some, but was not seen as a very important factor that influences their decision.
If someone feels healthy, they may not wish to risk their health by taking part in a trial. However, if someone feels unwell, they may not
want to risk making their health worse. On the other hand, someone who is healthy or very ill may feel they have “nothing to lose” by taking
part in a trial, so it is not just about how healthy someone is but rather how they feel about their own health.
Also, the person’s doctor or nurse may say something that influences their decision, as can something said by family, friends or in the
media. It is important for the people recruiting someone to know who has influence when that person is making their decisions.
People are influenced by the chance of improvement, the chance to feel better if the therapy or treatment works, or the opportunity to
make a di$erence by helping others in the future.
Inviting people to take part in a trial should be done in a way that considers each person individually, because there is no “one size fits
all” when it comes to making this decision.
How up-to-date is this review?
This review includes studies published up to 1 June 2017.
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis (Review)
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B A C K G R O U N D
Description of the topic
Randomised trials (also referred to as ‘randomised controlled
trials’ or, simply, ‘trials’) are the optimal way to minimise bias
in evaluating the e$ects of competing treatments, therapies and
innovations in health care. By design, randomised trials minimise
bias by o$ering a method that reduces the risk of systematic errors
compared to other types of studies used in healthcare research
(Burns 2011). They provide evidence to inform decision-making by
healthcare users, policy-makers, clinicians and other healthcare
professionals. In 2010, an estimated 75 trials evaluating healthcare
interventions involving medicinal products, devices and other
interventions were published globally each day (Bastian 2010).
The recruitment of potential participants is a process that trialists
need to accomplish, and it is known to be a challenging part of
any trial (Campbell 2007; Treweek 2018). Challenges in participant
recruitment are widespread. Estimates suggest that approximately
half of trials fail to recruit the target without an extension to time
or budget, or both (Charlson 1984; Haidich 2001; McDonald 2006;
Bower 2007; Sully 2013; Walters 2017).
If participant recruitment does not meet the target estimated
sample size, a trial runs an increased risk of finding no statistically
significant di$erence between intervention groups, even if one
truly exists (Thoma 2010). This threatens the utility of trial results
and raises important ethical questions about trial participation. If
trials recruit to target but su$er delays and timeline extensions,
this can result in increased costs, may delay the availability of
beneficial interventions to the public, or could allow harmful
or ine$ective interventions to be used for longer periods than
is ethically necessary (Watson 2006). In the very worst cases of
poor recruitment, a trial can stall entirely, potentially leading
to the premature stopping of the trial before the research
question has been answered. A study of 125 randomised trials,
funded by the National Institute for Health Research Health
Technology Assessment (NIHR HTA) program in the UK, reported
that five of these trials were ‘abandoned, stopped or closed down’.
Recruitment issues were a common theme across all five trials, with
participant recruitment ranging between just 0.25% and 20.8% of
target (RaTery 2015). A study of one US medical centre identified
260 trials ended prematurely due to poor recruitment (0 or 1
participant) over five years at a cost of almost $1 million (Kitterman
2011). The size of the abandonment problem is significant and
another study, of more than 1000 trials (two-thirds sponsored by
industry), found that 25% were abandoned, chiefly because of
recruitment problems, administrative issues and running out of
money (Kasenda 2014).
The reasons behind poor participant recruitment are diverse
and likely multi-layered, but it is clear that exploring factors
that contribute to the decision-making of potential participants
is an important part of the process to improve the situation.
Identification and understanding of determinants of decision-
making will provide trialists with the knowledge required to
implement methods and potentially remove barriers and introduce
facilitators that had not been used previously. Examples of
potential determinants may include perceived subtleties such
as methods of communication, or more fundamental aspects of
the process such as randomisation and use of a placebo. This
information could have implications on all aspects of the trial
timeline, including on retention (Daykin 2018). Understanding both
positive and negative influences on participants’ decision-making
has the potential to improve trial recruitment in regard to both the
experience of recruitment and the number of people enrolled.
Why it is important to do this review
Previous reviews of the literature exploring patients’ perspectives
of trial participation have focused largely on barriers to recruitment
and how to remove those barriers (Prescott 1999; Ross 1999; Hall
2010; Kanarek 2012). Whilst this body of work o$ers valuable
insight into potential reasons for poor recruitment, it focuses its
scope to factors that act to impede or hinder trial participation
only. This provides a partial picture of reasons that contribute to
the decisions that potential participants make. However, knowing
why potential participants do not participate in trials does not
provide constructive information on why they do participate in
trials. We are aware of reviews incorporating both barriers and
facilitators to recruitment, but these have focused specifically on
participation in trials for particular therapeutic indications such
as oncology (Mattel 2004; Fayter 2007; Kanarek 2010), or trials
within underrepresented populations such as indigenous people
(Glover 2015), women and minorities (Schmotzer 2012), and African
Americans, Latinos, Asian Americans and Pacific Islanders (George
2014).
An up-to-date comprehensive review of studies that explores
factors that create both barriers and facilitators which contribute
to the decisions made by potential trial participants, and covers
various clinical specialities across a range of healthcare settings,
provides a single point of access for information on participants’
views and experiences of the recruitment process for participation
in trials.
This Qualitative Evidence Synthesis (QES) builds on a published
Cochrane Review ‘Strategies to recruit participants to randomised
trials’ (Treweek 2018), and a second systematic review of non-
randomised evaluations of strategies to improve participant
recruitment to randomised trials (Gardner 2020), which provide
evidence on the quantitative e$ects of interventions to improve
recruitment to trials. QES is a robust approach to synthesising
primary qualitative research to capture experiences, perceptions,
and factors that impact on specific phenomena, in this case, certain
components of the trial process (Hennessy 2018). QES can inform
our understanding of intervention e$ectiveness by enabling a
deeper understanding of individual characteristics and attitudes
towards interventions (Noyes 2017a). This QES will provide trialists
and researchers with evidence that can be used to plan, design
and conduct recruitment strategies with participants’ experiences
in mind; thus, improving the experience of recruitment as well as
increasing the numbers of people enrolled in a trial. It is based
on the published protocol for this Cochrane Methodology Review
(Houghton 2017).
O B J E C T I V E S
To explore potential participants’ views and experiences of
the recruitment process for participation in trials. The specific
objectives were to:
• describe potential participants’ perceptions and experiences of
accepting or declining to participate in trials;
• explore the barriers and facilitators to participating in trials;
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis (Review)
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• explore to what extent the barriers and facilitators identified
were addressed by strategies to improve recruitment evaluated
in a previously published Cochrane Methodology Review
(Treweek 2018) and a systematic review (Gardner 2020).
M E T H O D S
Criteria for considering studies for this review
Types of studies
In this review, we explored qualitative primary research. Studies
that used and reported on widely accepted qualitative data
collection and analysis methods were eligible for inclusion.
Examples of data collection methods included individual and focus
group interviews, with findings that were reported explicitly and
illustrated by raw data (Finfgeld-Connett 2013). Mixed-method
studies that included a qualitative component of data collection
and analysis were eligible if the qualitative component was clearly
identifiable and suitable for extraction (Sandelowski 2007). In
addition, feasibility studies involving a qualitative component
utilising qualitative methods of data collection and analysis were
eligible.
Topic of interest
We included studies that examined the perceptions and
experiences of the recruitment process or specific recruitment
strategies to healthcare trials, or both. We excluded studies that
focused on retention or the experience of taking part in a trial rather
than the experience of being invited to participate.
The review explored the perceptions and experiences of potential
participants in randomised trials. The term “potential participants”
was defined as individuals, for example, patients or service users,
with direct experience of accepting or declining invitations to
participate in one or more randomised trial. To limit the size and
scope of the review, studies that focused on recruiting adults with
impaired cognition, or which focused on recruiting children were
excluded because the process of information giving and consent
would be rather di$erent for these studies.
Studies exploring recruitment in randomised trials in health care
were eligible for inclusion. A randomised trial is defined as a
study in which participants are allocated at random to receive
a specific intervention (this could involve medicinal products,
medical devices, lifestyle interventions, or surgery) or a comparator
(this could be a placebo, no intervention at all (i.e. standard
practice), or another intervention) (Treweek 2018). Feasibility
studies help to determine whether the study can be done on a larger
scale (Bowen 2009). They were included as potentially informative
about recruitment to trials. We excluded non-healthcare trials
and non-human, laboratory-based trials. Hypothetical studies were
excluded as potential participants do not have the experience of
being invited to participate in a trial. Studies that focused on the
recruitment of sites rather than individuals were also excluded. We
did not impose any geographical limitations.
Search methods for identification of studies
Searching for qualitative research is challenging due to unfocused
titles, inadequate indexing and other factors (Booth 2011).
Consensus has not been reached on whether systematic searching
is optimal for qualitative synthesis (Tong 2012). A “berry picking
model” of information retrieval (Bates 1989), has been supported
by other authors (Barroso 2003; Booth 2011; Finfgeld-Connett
2013), whereby searching for qualitative research is an iterative
approach rather than a report of linear search strategies. The
comprehensive approach that is necessary for a high-quality,
quantitative systematic review of clinical trials is not appropriate
for qualitative evidence syntheses (Booth 2016).
We conducted a scoping search to help formulate our research
question and identify key search terms. Three subsequent search
strategies were developed with input from two Information
Specialists and the author team. The first of these searches was
run in October and November 2016, and update strategies were
conducted in July 2017 and September 2019. Of these, only results
from the 2016 and 2017 searches have been incorporated into this
paper, and those from 2019 will be used in a future update.
Some resources used in the initial 2016 search were not included
in subsequent strategies. Due to resource constraints, the author
team chose to concentrate update searches on sources empirically
demonstrated to have a higher prevalence of included studies. We
did not search grey literature sources in the 2016 and 2017 update
strategies. We developed our strategies to be expansive rather than
exhaustive. Sensitivity was a lesser priority than the specificity of
the search and gauging this was an iterative process.
In Appendix 1, we present the search strategy used for the Embase
database in our 2017 search including field limiters. See Table 1
for additional information and the full list of electronic databases
and their platforms, grey literature sources, relevant websites and
professional body websites included in the 2016 searches and the
update searches in 2017. See Appendix 2 for the search terms and
limiters used in the update strategy conducted In September 2019.
We did not apply language or date restrictions in our 2016 or 2017
searches. However, some records were excluded on these grounds
at the screening phase and our update strategy in 2019 included
both restrictions. We did not apply geographic limits in any search.
The PRISMA and ENTREQ statements and MECIR manual were used
to guide the conduct and reporting of searches (Moher 2009; Tong
2012; Higgins 2016).
Search Results
See the 'Characteristics of included studies', 'Characteristics
of excluded studies' and 'Characteristics of studies awaiting
classification' tables.
In the 2016 search, we identified 3150 records from electronic
databases, 742 records through grey literature sources and one
record was found via Twitter. ATer deduplication and screening,
we identified 19 eligible records for inclusion in the review. The
most recent search for which results were incorporated into this
synthesis took place in July 2017. In this search, we identified 5090
records found through our electronic database searches and aTer
deduplication, screening and assessment of eligibility we identified
11 eligible records for inclusion in the review. Therefore, the total
number of records for which data were extracted was 30, which
reported 29 studies. See Figure 1 for our adapted PRISMA flow
diagram of the flow of information through the phases of this
qualitative evidence synthesis.
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis (Review)
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Figure 1.   Adapted PRISMA 2016/2017
 
In the 2019 update search, we found 10,391 records which have
not been incorporated into this review. See Figure 2 for an adapted
PRISMA flow diagram from this update strategy, which shows
how we dealt with the records (the process and total number of
records at the identification, screening, assessment of eligibility
and inclusion stages).
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Figure 2.   Adapted PRISMA 2019
 
Data collection and analysis
Selection of studies
Five review authors (CH, MD, PM, AH, HG, LB) worked in pairs to
independently screen the title and abstract of each citation against
the original inclusion and exclusion criteria. If there was uncertainty
or disagreement regarding whether a citation should be included,
two review authors discussed decisions in order to moderate and
resolve disagreements. Where necessary, another team member
was consulted to confirm and agree on decisions. The same process
was adopted for full-text screening.
We have included a table listing studies that we excluded from our
review at the full-text stage and the main reasons for exclusion
(Characteristics of excluded studies). Where the same study, using
the same sample and methods, was presented in di$erent reports,
we collated these reports so that each study (rather than each
report) was the unit of interest in our review.
Sampling of studies
We identified 86 studies that met our inclusion criteria. As large
amounts of data can impair the quality of the analysis we applied
the CART criteria to decrease the number of studies to a more
manageable amount. This approach has been successfully used
in a previous systematic review referring to the INTERUPT trial
(Whitaker 2016; Aslam 2017). The CART criteria are used to focus the
included studies using four broad criteria: Completeness, Accuracy,
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis (Review)









Cochrane Database of Systematic Reviews
Relevance and Timeliness (Table 2). The development of these
criteria was guided and supported by review author KS and her
colleagues in EPPI-Centre UCL, due to their experience in using
similar sampling techniques.
Data extraction and synthesis
Data extraction was managed using QSR NVIVO, which had been
successfully used by members of the team in the past (Houghton
2016a; Houghton 2016b). All PDF versions of the reports were
imported and coded in NVIVO using “Nodes”. Nodes are an NVIVO
term for what would be more commonly referred to in research
as codes signifying themes and subthemes (Houghton 2016b).
The attributes function facilitated the identification of pertinent
information about the trials and the studies that could be linked
to data to check the characteristics of synthesis findings (Bazeley
2007). Review authors CH, MD and AH extracted the data from each
of the included studies. NVIVO was a useful management system
because it facilitated synthesis from the studies in a comprehensive
and auditable way. It also facilitated the running of “queries” to
determine the adequacy of the data, as outlined in the assessment
of confidence in the review findings.
We synthesised qualitative data to determine the views and
experiences of being recruited to trials and the factors that act
as barriers and facilitators to potential participants’ willingness
to participate. We used the RETREAT framework developed
by Booth 2018 and deemed thematic synthesis as advocated
by Thomas 2008 as the most suitable based on the domains
of the framework, which are: Review question, Epistemology,
Timeframe, Resources, Expertise, Audience and purpose, and
Type of data. Thematic synthesis moves beyond description to
create analytical, and therefore more interpretive, themes (Thomas
2008). Thematic synthesis identifies three key stages: line-by-line
coding; developing descriptive themes and generating analytical
themes. The findings generated from thematic synthesis are
particularly useful to policymakers and practitioners (Booth 2016).
This approach is suitable for synthesis when larger numberS of
studies are included.
CH conducted line by line coding of each of the included studies.
This generated a high number of codes that were subsequently
developed into descriptive themes by the review team. NVIVO
provided the necessary auditability and information on coding
density needed for these discussions. The third stage involved
generating the analytical themes. This stage of the process
involves interpretation where the review authors will generate new
constructs and explanations. The review team (CH, MD, PM, AH, LB)
re-read the findings and discussed these at length to cross check
the general context against the subthemes and themes. The memo
function of NVivo was used to explore whether their interpretation
is a true representation of the combined attitudes and beliefs of
study participants. Review authors independently ‘went beyond’
the content of the original studies by considering the themes
against the original review questions. Once initial interpretations
were obtained, review authors discussed these interpretations as
a group and developed analytical themes (Thomas 2008). The
analytical level was further refined and represented as a new
model. We created a model to depict the core analytical findings.
Furthermore, the integration of the Qualitative Evidence Synthesis
(QES) with the prior intervention reviews facilitated new insights.
Assessment of methodological limitations in primary studies
We undertook an assessment of methodological limitations of
the included studies using the Critical Appraisal Skills Programme
(CASP) quality assessment tool for qualitative studies (CASP 2013).
This tool has been used in other reviews and protocols of QES
published by Cochrane (e.g. Glenton 2013; Ames 2017; Munabi-
Babigumira 2017; Karimi-Shahanjarini 2019).
Two members of the review team (LB, CH) independently applied
the CASP tool to each study to assess the methodological
limitations. Once both had completed their assessments,
comparisons of the two appraisals were made. Both review
authors discussed their ratings (as suggested by Noyes 2017b).
We conducted a pilot on five included studies. The pilot aimed to
ensure the feasibility of the tool and the integrity of the assessment
(Table 3).
The appraisal of methodological limitations was not used to
exclude studies. It is recognised that studies deemed to be of low
quality may still provide new insights (Dixon-Woods 2005; Noyes
2008). We did however use the appraisal as one of four components
in assessing our confidence in the findings from the reviews
(Lewin 2018). We considered the methodological assessment when
judging the relative contribution of each study to the development
of key findings.
Assessment of confidence in the review findings
Five review authors (CH, MD, PM, AH, LB) independently used
the GRADE-CERQual (Confidence in the Evidence from Reviews of
Qualitative research) approach to assess our confidence in each
finding (Lewin 2018). GRADE-CERQual assesses confidence in the
evidence, based on four key components.
1. Methodological limitations of included studies: the extent to
which there are concerns about the design or conduct of
the studies that contributed evidence to an individual review
finding.
2. Coherence of the review finding: an assessment of how clear and
cogent the fit is between the data from the studies and review
finding that synthesises those data. By cogent, we mean well-
supported or compelling.
3. Adequacy of the data contributing to a review finding: an overall
determination of the degree of richness and quantity of data
supporting a review finding.
4. Relevance of the included studies to the review question:
the extent to which the body of evidence from the studies
supporting a review finding is applicable to the context
(perspective or population, phenomenon of interest, setting)
specified in the review question.
ATer assessing each of the four components, we made a judgement
about the overall confidence in the evidence supporting each
review finding. Of the findings, only one was deemed of low
confidence. The overall moderate to high confidence could be
attributed to the fact that the CART criteria had been applied
for sampling purposes and so the included studies were highly
relevant.
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‘Summary of qualitative findings’ table
We have presented our summaries of the findings and our
assessments of confidence in these findings in Table 4. We present
detailed descriptions of our confidence assessment in Appendix 3.
Integrating the qualitative findings with the linked Cochrane
intervention review
On review of the di$erent approaches to integration, we agreed
that juxtaposing our findings in a matrix was the most suitable
method for this specific context. This method is visually quite
explicit and helps to identify gaps in research (Harden 2018). This
allowed a clear presentation of implications from the experiences
and perceptions of potential participants invited to be involved
in trials and any strategies identified in intervention reviews that
would address these implications for trial recruitment.
Four members of the review team (CH, HG, ST, LB) compared the
findings from our QES with two intervention reviews (Treweek
2018; Gardner 2020). From our summary of findings, we created
a table outlining the potential implications for trial recruitment
from those findings. We then juxtaposed these into a matrix
with the results from these two reviews (Table 5). It is evident
from the matrix that most recruitment interventions that have
been designed and evaluated by researchers do not directly
target factors that participants themselves consider important
when deciding on trial participation. It must be noted that the
Treweek review was able to identify some strategies that might
help recruitment, albeit with little certainty (Treweek 2018). In
the Gardner review of non-randomised studies of recruitment
strategies, the level of certainty in the findings themselves was so
low (Gardner 2020) that these are not presented and only the aims
of the included trials are presented in the table. This stark disparity
emphasises the need to use qualitative insights to understand what
is meaningful to potential participants and design recruitment
interventions and strategies that directly address these.
Review author reflexivity
We exercised reflexivity throughout this review both as individual
and group endeavours. Reflexivity, as used in primary qualitative
research enhances rigour by acknowledging personal responses
and contributions and can be used by each review team member
(Thorne 2004; Jasper 2005; Walsh 2005). As a group, moderation
meetings were held to discuss review findings and negotiate
decisions and we continually reflected on any potential biases or
preconceptions we held.
As with all qualitative endeavours, members of the team needed
to acknowledge their professional backgrounds, research areas of
interest and the impact these positions may have on all stages of
this QES. Several members of the group are healthcare clinicians
(CH, MD, PM, AH, JN, DD, LB). All review authors are researchers
within health care, some with a focus on trials, trial methodology
(HG, ST, DD, LB) and qualitative research in trials (CH, MD, PM, AH,
LB). Trial recruitment methodology is a topic area of interest to HG,
ST and DD, and these review authors are active researchers in this
area. CH, MD, PM, AH, KS, JN, LB have training and expertise in
qualitative research and the synthesis of qualitative studies.
Di$erent team members needed to have topic and methodological
expertise. These meant constructive discussions could take
place about individuals’ varying perspectives. Team members
were asked to identify their views about recruitment to trials,
thus ensuring we had a declarative statement that positioned
our thinking outside the experiences and perceptions of the
participants that inform the findings of this review. The view across
the team holds that trials of e$ects of healthcare interventions
can improve healthcare decisions. The team noted that trials are
dependent on recruiting and retaining participants; the voices of
recruiters and participants are necessary to better inform how this
is done.
R E S U L T S
Findings
Results of the search
We found 86 studies that met our inclusion criteria. We selected 29
of these studies (published in 30 papers) for inclusion in the analysis
(Figure 1). The sampled studies were published between 2004 and
2018.
Description of the studies
Study participants
The 29 studies in this review included the perspectives of 847
adult potential participants invited to participate in a randomised
trial. Seven studies explored the decliners’ perspective, 10 studies
explored the participants’ perspectives, and 12 studies included
both participants and decliners. Following the CART exercise for
purposeful sampling, very few studies included the perspectives of
recruiters, and if they did, their perspectives were not extracted for
this review.
Types of trials
Sixteen studies were conducted in the UK, six in other European
countries (Austria n = 1, Denmark n = 1, Germany n = 2, Sweden n = 1,
the Netherlands n = 1); three in the USA; and one each in Australia,
Canada, New Zealand and Tanzania. The trials into which potential
participants were invited were categorised by broad area of health
care: oncology (n = 7); pregnancy and childbirth (n = 5); medicine
and surgery (n = 11); mental health (n = 2); and health promotion
(n = 4). None of the papers included reported on recruitment
interventions as included in the two intervention reviews (Gardner
2020; Treweek 2018).
A variety of interventions (n = 25) were tested across the
included trials, with some studies including potential participants
across several trials. Interventions included, but were not
exclusive to: types of surgery, cognitive behavioural therapy
and other psychological therapies, pedometer use, HIV vaccines,
pharmaceutical treatments (anti-epileptic drugs, antibiotics,
intravenous (IV) morphine), umbilical cord clamping, acupuncture,
telehealth, pulmonary rehabilitation. These interventions were
also broadly categorised as: surgical (n = 4), psychosocial (n = 3),
pharmaceutical (n = 10), physical activity (n = 2), Complementary
Alternative Medicine (CAM) (n = 2), mixed trials (e.g. comparison
between surgical and pharmaceutical intervention) (n = 5), and
other (n = 3).
Approaches to recruitment
Study participants provided views about several di$erent
recruitment procedures employed in the trials. These included:
face-to-face invitation to participate during consultation with
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healthcare professionals; face-to-face invitation by research sta$
outside of a consultation; letter of invitation aTer being deemed
eligible by healthcare professional referral/medical records/
database; posters and flyers; telephone recruitment. Additional
strategies identified included using follow-up reminder letters and
reminder phone calls or using an “opt-out” strategy of recruitment.
Methodological limitations of the studies
We assessed 21 included studies as having no methodological
limitations, with six studies having minor and two having moderate
methodological limitations. Most studies clearly stated the aims,
described the recruitment strategy, appropriately collected data
and reported rigorous analysis. In all studies, we assessed the
findings as su$iciently supported by the underlying data. Across
most studies, there was poor reporting of the research design, so
it was di$icult to assess its appropriateness to the aims of the
research. In 12 of the studies it was di$icult to assess whether
the relationship between researcher and participants had been
adequately considered. In half of the studies it was not clear
whether ethical issues had been taken into consideration. See Table
3 for full details of the assessment of methodological limitations for
each study.
Confidence in the review findings
Out of 22 findings, we graded 14 findings as high confidence,
seven findings as moderate confidence, and one finding as low
confidence using the GRADE-CERQual approach (See summary of
qualitative findings in Table 4). Our explanation of the GRADE-
CERQual assessment for each review finding is shown in the full
evidence profiles in Appendix 3.
Review findings
We developed three broad themes (and six subthemes) outlining
the factors influencing potential participants’ decisions about
whether to participate in a randomised trial (Table 6). Our 22 key
findings are presented within these themes.
Theme 1: Trial influences on decision to participate
This theme examines the factors relating to the trial itself on
potential participants’ decision to enrol in a randomised trial.
These factors focus on two subthemes: communication of trial
information and significant trial components.
Communication of trial information
Finding 1: Trial information delivered verbally during face-to-
face communication can be less confusing than written trial
information (we have high confidence in this finding)
Potential participants believed that written information about the
trial may have less influence than verbal information on their
decision to participate in a trial (Attwood 2016; Dellson 2018).
Written information could also be considered more confusing,
with less opportunity to ask questions (Barnes 2012; Moynihan
2012; Oud-Rengerink 2015). Some participants from cancer and
medical trials were more reassured by face-to-face contact with
a healthcare professional than a letter (Moynihan 2012; Bleidorn
2015; Dellson 2018). As identified in the study by Bleidorn 2015,
“The communication with the [family physician] reassured some
patients more than the information sheet – they highly valued the
personal information and discussion of the trial which made them
feel safe” (p.6).
Finding 2: Written trial information may be beneficial as an
adjunct to verbal information and facilitates time and space for
reflection without the added influence of recruiters’ presence
(we have high confidence in this finding)
Some participants (primarily in pregnancy and gynaecological
trials, with one psychotherapy trial) found letters appealing
because they allowed for potential participants to decide whether
or not to participate in their own time (Hughes-Morley 2016; Sawyer
2017), acting as an adjunct to verbal information provided by a
healthcare professional (Jackson 2010; Smyth 2011; Sawyer 2017).
For others (again primarily women invited to trials for urinary tract
infection, dysmenorrhoea and infertility), written information, in
the form of posters or letters, was su$icient for them to take a
decision to participate and they did not feel the need to consult with
anyone else (Bleidorn 2015; Blodt 2016; de Lacey 2017).
One individual who declined participation in a therapy trial for
treatment resistant depression believed, “The letter is a good
idea…I mean if they sign you up you have to decide very quickly
and you don’t have time to chew over the information, so having a
letter makes sense, you can sit and think about it and decide what
to do” (Hughes-Morley 2016, p4).
Finding 3: The person delivering trial information should have
good communication skills, be approachable, trustworthy,
person-centred and knowledgeable with a good ability to
address potential participants’ queries. Consideration needs
to be given to whether a clinician or a researcher is the most
appropriate person to provide the trial information (we have
high confidence in this finding)
Across all intervention types, when trial information was delivered
in person, potential participants valued the demeanour and
approachability of the individual delivering the information (Chang
2004; Costenbader 2007; Moynihan 2012; Ballantyne 2017; Sawyer
2017), and a human, person-centred approach to the research was
viewed favourably (Madsen 2007b; Bleidorn 2015). Irrespective of
the intervention, several study authors concluded that delivery of
trial information should come from someone knowledgeable who
has good communication skills and can take the time to answer
potential participants’ queries (Costenbader 2007; Jackson 2010;
Tarimo 2010; Oud-Rengerink 2015).
Potential participants invited to join cancer trials had concerns
as to whether the recruiting clinician was trying to steer them
towards a decision to participate based on their knowledge of the
intervention (Abhyankar 2016). Additionally, potential participants
did not like the feeling of being under pressure to consent
(Moynihan 2012; Sawyer 2017). Participants from cancer trials
(surgical and pharmaceutical) were, at times, suspicious about the
motivation, regulation and the role of pharmaceutical companies
in influencing physicians who provided trials information (Madsen
2007a; Moynihan 2012). Two studies identified mixed views as to
whether the clinician or a member of the research team should
provide the trial information (Smyth 2011; Sawyer 2017).
One woman who agreed to participate in a pregnancy and
childbirth trial, asserted that “He [recruiting doctor] was very calm
throughout the whole process … It was very much he talked to me
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directly, very clearly, concisely, didn’t mince his words, didn’t beat
around the bush. Just very professional and very clear on what he
was wanting and what was being said to me” (Sawyer 2017, p.4).
Finding 4: Potential participants value trial information that
is robust yet concise, free of medical jargon, clearly identifies
options, time commitment, randomisation process, treatment
equivalence, intervention details, potential benefits and side
eIects. This could be made available in hard or soJ copy, or
both before a decision on participation is expected (we have
high confidence in this finding)
Potential participants appreciated good quality information on the
features of the trial (Jackson 2010; Hughes-Morley 2016) and in
some studies, those who decided to participate reported receiving
adequate information (Jackson 2010; Harrop 2016a; Sawyer 2017).
Potential participants in some studies sought “comprehensive"
and "extensive" information about trial participation that was free
of medical jargon (Taylor 2007; Habersack 2013, Oud-Rengerink
2015). Participants, primarily in pharmaceutical and some surgical
trials, wished for the detail about options, drug doses, risks and
side e$ects at the recruitment stage rather than post consent and
indicated that the decision to participate could be hindered by lack
of information (Canvin 2006; Costenbader 2007; Madsen 2007b,
McCann 2010; Smyth 2011; Abhyankar 2016).
In contrast, however, some potential participants could be
deterred by information overload (Smyth 2011; Oud-Rengerink
2015; Bidad 2016; Harrop 2016a), and some indicated that simple
straightforward information was preferable (Ballantyne 2017).
Participants in cancer trials, some of whom felt they had “nothing to
lose” through participation, did not wish for the same level of detail
to inform their decision (Dellson 2018). Participants also wanted
to know about the exact time commitment expected from them if
they participated in the trial (Attwood 2016; Blodt 2016). Potential
participants required a clear explanation of randomisation and
treatment equivalence (Canvin 2006; Madsen 2007b; Moynihan
2012; Bidad 2016), but at a time when they are not trying to receive
information around treatment and diagnosis (Madsen 2007b).
Habersack 2013 identified that “when responding to the question
related to how they remember their physician’s briefing regarding
the study, more than half of the interview partners referred to the
extent and the manner of sharing information. The participants
described the briefing predominantly with the words ‘‘extensive’’,
‘‘comprehensive’’ and ‘‘comprehensible’’. In contrast, the non-
participants indicated more short briefings (Habersack 2013, p.5).
Finding 5: The timing of trial information is important as
the potential participant needs to be able to consider the
trial information without confusing it with their diagnosis and
standard treatment (we have high confidence in this finding)
Regarding the timing of presenting trial information, it was
important to consider when the potential participant had received
their diagnosis, if relevant, and their reaction to it (Madsen
2007b;Smyth 2011; Moynihan 2012; Habersack 2013; Abhyankar
2016; Hughes-Morley 2016; Sawyer 2017; Dellson 2018). In some
cases, recruitment to a trial began when they were still in
shock over their diagnosis. In an oncology trial for instance,
potential participants were trying to di$erentiate between
information regarding their diagnosis and standard treatments,
from information about the trial (Abhyankar 2016). In this study
(Abhyankar 2016), trial information was delivered during clinics,
either while in consultation or outside of consultation by research
sta$.
For example, one woman invited to an oncology trial for breast
cancer, found it di$icult to distinguish between standard treatment
options and the trial, ‘When I was diagnosed with my lung
secondaries, I was … I don’t know what the alternative was, …any
way … various chemos were run past me, like “we could do this or
we could do the other” …… and by the way, there is a trial on Taxol.
Mm and that was broadly what I was told […]’ (Abhyankar 2016,
p.88).
Significant trial components
Finding 6: Potential participants consider participation
disruptive and a burden when additional appointments or
travel, or both are needed. Perceived time commitment as a
result of trial participation was also identified as a concern for
potential participants (we have high confidence in this finding)
Certain aspects of the trial itself could impact on potential
participants’ decision to enrol in a trial. For instance, some
potential participants, across a variety of trials, viewed trial
participation as disruptive, burdensome, and some wanted to
"avoid the hassle" of additional appointments (Canvin 2006;
Costenbader 2007; Habersack 2013; Attwood 2016; Hughes-Morley
2016; Ballantyne 2017). As illustrated by one participant who
declined participation in a therapy trial for depression, “the long-
term commitment was a nightmare for me as I was looking for work,
going for interviews and not really knowing what I would be doing
or where I would be over the next 18 months” (Hughes-Morley 2016,
p.8). This was not the perception of those in the study by Gopinath
2013 but follow-up appointments in this trial were conducted over
the telephone rather than in person.
Potential burden of trial participation was a particularly important
factor when the individual’s health was perceived as stable or
"good" (Costenbader 2007), or if individuals wanted immediate
treatment without any trial "nonsense" (Harrop 2016a). It was
common to cite the potential time commitment as another barrier
to participation (Costenbader 2007; Bleidorn 2015; Attwood 2016;
Hughes-Morley 2016; Normansell 2016; Ballantyne 2017). The
prospect of participating in a trial could also seem daunting
(Attwood 2016).
Finding 7: A financial benefit in terms of an incentive or
reimbursement may not be an overly influencing factor
for potential participants. However, it is viewed as a
welcome acknowledgement of participants’ time and eIort.
Other incentives that may be welcome include additional
health checks or medications that potential participants may
otherwise not be able to aIord (we have moderate confidence
in this finding)
Sometimes, trial participation could include financial
reimbursement and this influential factor was explored in some
of the included studies. Only one study identified financial
reimbursement as an important factor impacting on the decision
to participate (Wasan 2009). More so, financial reimbursement was
seen as a nice "bonus" that participants were grateful for (Blodt
2016; Chin 2016). It was perceived as a good acknowledgement
of time and e$ort (Blodt 2016; Chin 2016). However, Blodt
2016, in relation to recruiting to an acupressure trial for
dysmenorrhoea, concluded that reimbursement would not impair
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potential participants’ judgement of risks and benefit when making
decisions about trial participation. Compensation was oTen not the
sole reason for participation (Chang 2004; Costenbader 2007; Blodt
2016; Chin 2016). As Chang 2004, concludes, “while some patients
said that the monetary compensation was a nice feature and they
were happy to get it, they stressed that they would have joined the
study even without the money” (Chang 2004; p.8). In addition to
direct financial incentive, participants felt that they could benefit
from interventions (Chang 2004, de Lacey 2017), health checks
(Tarimo 2010), or medications (Bleidorn 2015) that they could not
otherwise a$ord. These studies were conducted in Australia, USA,
Tanzania and Germany, where access to health care varies from
public to private systems.
Finding 8: Potential participants’ perceptions of randomisation
and freedom to withdraw from the trial were important factors
in their decision whether to participate in a trial. This was
particularly important if they did not fully understand the
concept of randomisation or if they had a treatment preference
(we have high confidence in this finding)
Potential participants’ perceptions and understanding of
randomisation, equipoise and treatment preferences were
significant in influencing their decision to participate. It was
important to participants that they understood the concept
of randomisation (Madsen 2007a; Madsen 2007b; Taylor 2007;
Bidad 2016). For many potential participants, the uncertainty of
being randomised was a barrier to participation (Canvin 2006;
Madsen 2007a; Madsen 2007b; Moynihan 2012; Bleidorn 2015; Oud-
Rengerink 2015; Harrop 2016a). In particular, potential participants
felt that being randomised to the placebo group would be an
unnecessary burden because they would not have the chance of
a new treatment (Habersack 2013; Bidad 2016; Ballantyne 2017).
This was particularly evident where potential participants wanted
the intervention (in these studies, chemotherapy, psychological
therapies and probiotics) and not receiving it was perceived as
"cruel" (Madsen 2007b; Hughes-Morley 2016; Ballantyne 2017).
There was also the perception among potential participants
that one treatment was preferable over the other (Madsen
2007a; Jackson 2010; Gopinath 2013; Oud-Rengerink 2015; Bidad
2016; Harrop 2016a; Normansell 2016). Treatment preference,
primarily in surgical and pharmaceutical trials, was a key factor
in decision-making and could determine agreement to participate
or not (Canvin 2006; Madsen 2007b; Jackson 2010; McCann 2010;
Moynihan 2012; Gopinath 2013; Bleidorn 2015; Oud-Rengerink
2015; Bidad 2016; Harrop 2016a; Normansell 2016). In other words,
potential participants were less likely to accept randomisation if
they had a clear preference for a particular treatment. As one
pregnant woman outlined, “I would happily have taken part if I
could have opted for iron tablets, but that choice wasn’t available.
You have to participate blind, and then I don’t know who decides.
I don’t know how that works, but someone else decides for you
which of the two you are going to do.” (Oud-Rengerink 2015).
Randomisation by computer or "drawing of lots", or both
was a particular issue; potential participants had a feeling of
treatment allocation being "pot luck" and "throwing a dice",
rather than a more informed clinical decision (Canvin 2006;
Madsen 2007b; Jackson 2010; Bidad 2016; Harrop 2016a). While
equipoise was oTen purported, potential participants felt the
healthcare professionals themselves implied that one treatment
was preferential (Jackson 2010). Randomisation was more
acceptable to those wishing to contribute to knowledge and science
and trusted recruiting physicians (Jackson 2010; Blodt 2016). It
was also more acceptable to those who perceived equivalence
between treatments being randomised (Canvin 2006; Jackson
2010). In some studies, potential participants valued knowing that
they could withdraw at any time, particularly aTer randomisation
(Canvin 2006; Madsen 2007a; Jackson 2010). Knowing the decision
to participate was voluntary acted as a facilitator (Canvin 2006;
Madsen 2007b; Smyth 2011; Abhyankar 2016; Sawyer 2017; Dellson
2018). It was also important to know that they could withdraw
from the study at any time (Sawyer 2017). Alternatively, some
participants felt they had to participate and that they had no
choice (Moynihan 2012). In these two studies, it was the clinician,
who provided the trial information, but in the Sawyer 2017 study,
potential participants emphasised the caring, supportive and non-
pressurised way in which the trial information was delivered.
Recruiters must be cognisant of how they portray information and
avoid therapeutic misconception: ensuring potential participants
can di$erentiate between the randomised trial and routine care
(Abhyankar 2016).
Theme 2: Personal influences on decision to participate
In this theme, we present personal and external influences on the
decision to participate in a trial. These were developed into two
subthemes: the influence of others on the person’s perceptions of
trial participation and weighing up the risks and benefits.
Influence of other people
Finding 9: The decision to participate is discussed with a
range of other people; family, friends, healthcare professionals,
previous trial participants (we have high confidence in this
finding)
Potential participants oTen sought advice from family and friends,
particularly those with a healthcare background or previous
experiences of the trial/intervention (Madsen 2007b; Gopinath
2013, Habersack 2013, Chin 2016, Harrop 2016a, Hughes-Morley
2016, Ballantyne 2017). In the case of trials in pregnancy and
childbirth, in most cases, both the woman and her partner needed
to agree before decision-making (Oud-Rengerink 2015; Ballantyne
2017; de Lacey 2017). However, in some instances, the woman
made the decision alone or with minimal partner influence (Smyth
2011; Ballantyne 2017). Similarly, in cancer trials, participants felt
there was no option but to take part and so did not consult
with their families in their decision-making (Dellson 2018). When
potential participants had contact with previous trial participants,
they could also provide insight into treatment options (Harrop
2016a), their benefits (de Lacey 2017) or their possible side e$ects
(Gopinath 2013; Abhyankar 2016). One potential participant who
declined enrolment in a surgical trial for bladder cancer stated, “My
sister lives in America and she, her in-laws work in hospitals, micro-
biologists, technicians sort of thing. So I got them to um tell me
what they thought, they’d all worked in where the robot had been
um and came back with you know way to go you know, if you get a
choice don’t do anything else sort of thing” (Harrop 2016a, p6).
Finding 10: Healthcare professionals in particular may
influence decision-making as potential participants place huge
trust in them. This results in great potential for influence
by healthcare professionals being a key impact on decision-
making (we have high confidence in this finding)
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Some sought advice from a healthcare professional (nurse,
midwife, obstetrician, family physician) unrelated to the trial to
gain their expertise on the condition and related intervention
(Costenbader 2007; Madsen 2007b; Gopinath 2013; Habersack
2013; Oud-Rengerink 2015; Abhyankar 2016; Ballantyne 2017).
Across a broad range of trials, potential participants oTen placed
great trust in healthcare professionals, particularly those known
to them, involved in recruiting to the trial, and believed they
would only support trial participation if they believed that it was in
the best interest of the potential participant (Chang 2004; Canvin
2006; Madsen 2007b; Jackson 2010; Smyth 2011; Moynihan 2012;
Habersack 2013; Bleidorn 2015; Bidad 2016; Harrop 2016a; Hughes-
Morley 2016;Dellson 2018). Their perceived trust in the recruiting
physician meant nothing "bad" could happen to them (Madsen
2007b; Bleidorn 2015). Some participants from pharmaceutical and
surgical trials felt their healthcare professionals had an implicit
preference and would only suggest they enrol into a trial if there
was a potential benefit or therapeutic e$ect. (Canvin 2006; Jackson
2010; Moynihan 2012; Harrop 2016a). To explain, why he had agreed
to join a bladder cancer trial, one participant said “..he/she’s a
(doctor) who instils confidence in you .....and that is one of the
things that was a consideration when push came to shove and I
had to decide which way it (participation) was going....” (Moynihan
2012, p.4).
In contrast, some potential participants distrusted recruiting
clinicians and believed external control of trials (through ethics
and regulation) was important (Madsen 2007a; Ballantyne 2017).
Potential participants' decision could be impacted if the recruiting
healthcare professional indicated a lack of knowledge or inability
to articulate the trial properly (Smyth 2011).
Finding 11: Internet searching and exposure to media sources
with information on trial interventions may act as either a
barrier or a facilitator for trial participation (we have low
confidence in this finding)
Potential participants also sought information from the Internet
on the trial/intervention and the associated risks (Gopinath 2013;
Habersack 2013; Harrop 2016a; Ballantyne 2017; de Lacey 2017.
This information could act as a facilitator (de Lacey 2017) or barrier
(Gopinath 2013) to trial participation. Doing their investigations on
the Internet could supplement the trial information or, in some
cases, lead to preferences for certain treatments (Harrop 2016a).
Those who did not access the Internet avoided it for fear of "bad
news" (Habersack 2013). As one woman invited on to a breast
cancer trial said, “…also can research a little, perhaps also on the
internet, though I don’t like to do that so much. Of course, I did it
before, but. … I talked with my doctor today anyhow. He also says
that, most of the time, those who write are those who have had
negative experiences; where the surgery failed” (Habersack 2013,
p3).The media and television could also influence decision-making
(Madsen 2007a; Gopinath 2013; Bleidorn 2015), either negatively
(Madsen 2007a; Bleidorn 2015) or positively (Gopinath 2013).
Weighing up the risks and benefits
Finding 12: Potential participants may view trial participation
as feeling like a guinea pig (i.e. being used for the experiment),
which they considered as too risky (we have moderate
confidence in this finding)
The perceptions of personal harm and benefit were critical
considerations for trial participation. Potential participants
commonly equated trial participation to being a "guinea
pig" (Chang 2004; Canvin 2006; Taylor 2007; Moynihan 2012;
Gopinath 2013; Habersack 2013; Bleidorn 2015; Dellson 2018), and
for some that was too risky to agree to take part in the trial
(Costenbader 2007; Bleidorn 2015; Oud-Rengerink 2015). One man
who declined participation stated, “all I knew is ( ) you are going
as a human guinea pig and they can do what they like..” (Moynihan
2012, p 8). There could be a perceived risk from taking tested drugs,
either through a belief in non-e$ect or side e$ects (Canvin 2006;
Costenbader 2007; Madsen 2007a; Madsen 2007b; Tarimo 2010;
Habersack 2013; Bleidorn 2015; Oud-Rengerink 2015). A woman
who declined participation in a trial for urinary tract infections
asserted, “and fundamentally I was not opposed, however (...) but
when he told me that I will get a drug as part of this study (...) then I
kept my distance. (...) because I was thinking: Well, you do not need
drugs actually. Maybe just a homeopathic remedy or something like
that to solve the whole problem.” (Bleidorn 2015, p.7).
Finding 13: The risk of participation may concern potential
participants who view their health as good or they are healthy
and worried that the trial would identify a health problem.
Potential participants may deem themselves ineligible and
decline if they have too many health problems (we have high
confidence in this finding).
People did not want to risk their health further, either when they
were sick and did not want to get worse; or feeling well and did
not want to "rock the boat" (Costenbader 2007; Bleidorn 2015;
Normansell 2016), as identified by one decliner, “It’s like I’m feeling
good right now. Don’t bother me with all that now. I am living my
life” (Costenbader 2007, p.52).
Perception of risk could vary for individuals based on personality
and previous positive or negative experience of healthcare systems
(Gopinath 2013; Harrop 2016a; Ballantyne 2017). Some just did
not like the intervention, for example, a walking programme
or telehealth (Sanders 2012; Oud-Rengerink 2015; Normansell
2016). Some participants declined, deeming themselves ineligible
because they were too healthy and just wanted to get on "with
everyday life" (Canvin 2006; Costenbader 2007; Barnes 2012;
Bleidorn 2015; Attwood 2016; Hughes-Morley 2016), or felt they
had too many co-morbidities and that participating in a trial
would be an additional burden (Barnes 2012; Attwood 2016; Harrop
2016a;, Hughes-Morley 2016). As one decliner outlined, “well at
the moment I’ve got other health problems... and I didn’t want
to be bothered with any more things to have to sort of connect
me with hospitals ... I’m diabetic, got asthma, and chronic kidney
disease’ (Barnes 2012, e375).
Finding 14: If potential participants sense a trial was safe, low
risk, and would not impact on existing treatments they may feel
they have nothing to lose if they participate (we have moderate
confidence in this finding)
In some cases, agreement to participate was less about potential
benefit but rather lack of identification of "active harm" (Canvin
2006; Oud-Rengerink 2015). If the trial intervention (for example
probiotics, acupressure) was considered to have very low risk or not
jeopardise existing treatments, or both, there was little proposed
risk to themselves (or baby in pregnancy trials) thus facilitating
participation (Madsen 2007a; Bleidorn 2015; Oud-Rengerink 2015;
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Bidad 2016; Blodt 2016; Ballantyne 2017; de Lacey 2017; Sawyer
2017). This resulted in a sense of safety that nothing "bad" could
happen and there was "nothing to lose" (Jackson 2010; Bleidorn
2015; de Lacey 2017). As one woman who accepted participation
in a cord clamping policy trial, it was a “very easy decision, to be
honest, because I knew there would be no danger to the baby to be
leT on the cord. I would have never if there was a risk, but I felt that
there was no risk so there wasn’t any query of it really. It was easy
as that” (Sawyer 2017, p.6).
Finding 15: If potential participants consider themselves
desperate, they may feel they have nothing to lose if they
participate (we have moderate confidence in this finding)
“Nothing to lose” could also capture the feeling of desperation of
the situation prior to the trial invitation (living with chronic pain or
having a cancer diagnosis) and the need to regain control (Madsen
2007b; Blodt 2016; de Lacey 2017; Dellson 2018). The perception
of having nothing to lose was important for those with a diagnosis
of cancer as participation was seen to be preferable over "doing
nothing" [standard care] (Abhyankar 2016; Dellson 2018). This
could also mean keeping optimistic in the face of their diagnosis
(Habersack 2013). In the case of cancer diagnosis, there was no
perceived risk as trial participation was "life or death" (Abhyankar
2016; Dellson 2018). Likewise, in pre-eclampsia, there was a similar
feeling of life or death for both mother and baby (Smyth 2011).
The deliberation between what potential participants had to lose
or gain was prominent regardless of the type of trial or intervention.
As one woman suggested, “so it’s as I said. I’m sick once a month
and I find that quite a limitation given the fact that it’s [menstrual
pain] not a disease. … And I just hoped that something could help.
That I could just … cope with my everyday life. … Because up to
now there has been no solution (Blodt 2016, p.5).
Theme 3: The impact of potential outcomes on decision to
participate
Within this theme, we explore the potential outcomes of trial
participation. The potential benefits of trial participation could be
personal or for the benefit of others, therefore two subthemes were
identified: 'Personal benefits of trial participation' and, 'Making a
di$erence: benefits for others'.
Personal benefits of trial participation
Finding 16: Potential participants recognise the benefit of
access to new or existing treatments through trial participation
(we have high confidence in this finding)
Potential participants were more likely to agree to participate when
they could anticipate a positive impact on their care (Madsen
2007a; Madsen 2007b; McCann 2010; Oud-Rengerink 2015). Overall,
potential benefits included receiving treatments, oTen new or
alternative to standard care (Canvin 2006; Wasan 2009; Jackson
2010; Smyth 2011; Habersack 2013; Oud-Rengerink 2015; Blodt
2016; de Lacey 2017; Dellson 2018). As one participant said,
“because I have chronic back pain and I’m not happy with the
medication I’ve got, and I’m interested in either finding something
better, or at least helping with the process of researching it” (Wasan
2009, p.115).
Conversely, in the case of decliners, it was the perceived lack
of personal benefit from the intervention that impacted on their
decision (Bidad 2016). Some potential participants felt there was no
benefit from trial participation due to a lack of personal relevance
(Attwood 2016; Bidad 2016). For some, in the case of two similar
treatments for stress incontinence, it was that they did not see
one intervention as having greater potential value over another
(Gopinath 2013). Some decliners had experienced an intervention
(e.g. counselling) before, disliked it, and so did not want to receive
it again (Barnes 2012).
Finding 17: Potential participants recognise that being in a
trial may mean quicker access to services, better follow-up
care, increased contact time with physicians and a chance to
learn more about their condition, as potential benefits to trial
participation (we have high confidence in this finding)
Potential impact on care could also be perceived as the opportunity
to have a health check secondary to trial participation (Tarimo
2010; Attwood 2016; Dellson 2018), quicker access to services
(McCann 2010); better follow-up care, and increased contact
time with physicians (Wasan 2009; Jackson 2010; McCann 2010;
Habersack 2013; Bidad 2016); or learn more about their condition
and ways to manage it (Chang 2004; Costenbader 2007; McCann
2010). In pregnant women, this benefit could be for the unborn
child and seemed like the "natural thing to do” (Oud-Rengerink
2015; Sawyer 2017). As one woman in a breast cancer trial
suggested, “and I believe, if I weren’t participating in the study, I
don’t know if it would be as precise and personal with the follow-
up care ..Of course I am examined regarding my spine every six
months; so that is automatically better. Otherwise I would not
receive that” (Habersack 2013, p.3).
Finding 18: Potential participants may be managing symptoms
for some time with feelings of desperation and trial
participation brings hope of relief (we have moderate
confidence in this finding)
Trial participation brought with it the "hope" for relief of symptoms
such as chronic back pain, reflux, dysmenorrhoea or urinary tract
infections; which in some instances potential participants had
been self-managing for some time (Wasan 2009; McCann 2010;
Bleidorn 2015; Blodt 2016). This oTen manifested as a feeling
of desperation of the situation before the trial invitation, where
potential participants felt out of options other than to participate
(Madsen 2007b; Blodt 2016; de Lacey 2017; Dellson 2018). As one
participant in an oncology trial said, “And you can’t ask to have
this treatment any other way. The only chance to get it is if you
participate in the study” (Dellson 2018, p.5).
Making a diIerence: benefits for others
Finding 19: Altruism can be an important factor influencing
potential participants’ decision to participate in a trial (we have
high confidence in this finding)
Altruism was oTen cited by potential participants as an important
motivating factor, contributing to improved care for others in the
future (Chang 2004; Canvin 2006; Costenbader 2007; Madsen 2007a;
Wasan 2009; McCann 2010; Smyth 2011; Moynihan 2012; Habersack
2013; Bleidorn 2015; Oud-Rengerink 2015; Bidad 2016; Harrop
2016a; Hughes-Morley 2016; Ballantyne 2017; de Lacey 2017;
Dellson 2018). As outlined by one participant, “I can remember
reading things, something that said look, it might not necessarily
benefit you and I can remember thinking that of the people that
have tried out drugs and techniques before I was trying to get
pregnant [and how] that’s helped me. If I can be part of something
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that maybe I will get some benefit from [and if I don’t] maybe
somebody else in 10 years’ time will get benefit out of it” (de Lacey
2017, p5).
Even those who declined participation acknowledged the value of
research in helping other people (Bidad 2016). Some believed that
altruism and a desire to help others was down to personality type
(Bleidorn 2015; Bidad 2016; Ballantyne 2017). Chin 2016 identified
di$erent typologies of altruism: cultural, community, familial,
professional, religious, political, experiential, moral, existential
and psychological. A combination of these influenced potential
participants’ altruistic motives.
Finding 20: Altruism can be conditional whereby potential
participants’ desire to help others is dependent on the trial
being low risk and with clear benefits (we have moderate
confidence in this finding)
There was a certain amount of conflict between the desire to help
other people and personal risk (Abhyankar 2016; Attwood 2016).
As outlined by one woman invited on to a breast cancer trial,
“’cos you do sometimes think you know you are helping other
people by doing this, but then sometimes you think I don’t want
to help anybody else, I want to look aTer myself” (Abhyankar
2016, p.87). The decision was more straightforward in cases where
the perceived personal risk was low (Chang 2004; Canvin 2006;
Oud-Rengerink 2015). Conversely, it was more significant in more
life-changing diagnoses such as cancer (Bidad 2016). Sometimes
altruism and personal benefit went hand in hand, whereby if the
"community" would benefit, then the individual would also (Canvin
2006). Altruism was sometimes secondary to personal benefit
(Jackson 2010), implying conditional altruism, whereby there must
also be personal benefits from participation (McCann 2010; Bidad
2016).
Pure altruism was recognised as acceptance of randomisation even
when it was not the preferred treatment/intervention (Bidad 2016).
Alternatively, hypothetical altruism is seen where participants
were allocated to their preferred treatment but said they would
have participated regardless of allocation (Jackson 2010; Bidad
2016). There was evidence that this may have been due to a
misunderstanding of randomisation (Bidad 2016). Bidad 2016 also
identified weak altruism where participants had no real treatment
preference going into the trial.
Finding 21: Potential participants may feel an obligation or a
moral duty to participate in a trial as a way of “giving back” (we
have moderate confidence in this finding)
Rather than altruism per se, some potential participants felt more
of a duty to participate (Bidad 2016). It was considered a way to
"give back", "pay back" and "do your part" (Canvin 2006; Bleidorn
2015; Bidad 2016; Ballantyne 2017), and sometimes seen as a moral
obligation (Madsen 2007a; Tarimo 2010; Chin 2016; Ballantyne
2017), for religious reasons (Tarimo 2010), and in the case of one HIV
vaccine trial, as atonement for previous wrong doings (Chin 2016).
This brought a sense of pride in their contribution (Tarimo 2010;
Chin 2016). One male invited on to a HIV vaccine trial outlined, “I’ve
been part of negative stu$ all my life. I ran the streets for a long time.
I did drugs so many years. I tore down my community. I sold and did
a lot of drugs. I hurt a lot of people. So eventually, I mean: I don’t
do nothing negative no more, so I’m going to be part of something
positive. Now I want to help” (Chin 2016, p.9).
Finding 22: Potential participants may have a genuine interest
in contributing to scientific knowledge and improved care (we
have high confidence in this finding)
For some potential participants, there was genuine curiosity and
interest in contributing to the trial and scientific knowledge.
Participants recognised the value of trials adding to new knowledge
and improved care (Chang 2004; Canvin 2006; Madsen 2007a;
Wasan 2009; Smyth 2011; Moynihan 2012; Habersack 2013;
Bleidorn 2015; Oud-Rengerink 2015; Bidad 2016; Hughes-Morley
2016; Ballantyne 2017; de Lacey 2017; Sawyer 2017; Dellson 2018).
This included being part of a larger endeavour, contributing to the
bigger picture (Chin 2016; de Lacey 2017) and "doing something
about it" (Hughes-Morley 2016). As one woman invited on to a cord
clamping trial suggested, “Basically, I think it’s like anything, isn’t
it. Without research you don’t find out about things, so I totally
support research. That was our feeling behind it, that, you know, if
you don’t research these things, you don’t find out about it, do you?
We’re completely open to research, and we think it’s a good thing,
so it was important to take part” (Sawyer 2017, p.6).
Contribution to science and knowledge was recognised particularly
with those who were familiar with research professionally (Bleidorn
2015; Oud-Rengerink 2015), from participating in previous studies
(Oud-Rengerink 2015), or benefiting from previous research
(Bleidorn 2015; Oud-Rengerink 2015). This contribution helped to
seek solutions to existing unsatisfactory or ine$ective treatments
(Bleidorn 2015; Blodt 2016), and pioneer new interventions (Harrop
2016a). Decliners also noted the need to contribute to science
(Harrop 2016a; Hughes-Morley 2016; Normansell 2016).
Conceptual model
From these themes, we concluded that for potential participants,
the ultimate question was, “will I take part?”. To illustrate this, we
developed a conceptual model (Figure 3) based on the concept
of a gauge, whereby a potential participant decides ultimately
whether to take part in the trial. The factors that impact on whether
they participate can tip the gauge towards accepting participation
or declining participation. The factors that tip the gauge towards
declining include trial burden, feeling they have something to lose,
or nothing to gain. How trial information is communicated may
also tip the person towards declining as may the discouragement
of other people. The factors that could tip the gauge towards
accepting participation include the belief there is something to
gain, the chance to make a di$erence and the sense that there
is nothing to lose by participating. Again, how trial information
is communicated, and the encouragement of others may incline
some towards accepting participation.
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Figure 3.   Conceptual model
 
As an example, a potential participant, who perceives themselves
as healthy, may feel they have nothing to gain by participating in
a trial. If the trial is deemed risky, inconvenient or burdensome,
they may also feel that they have something to lose and so
the gauge tips towards declining. Another example may be an
individual with a life-limiting condition. They may not benefit
personally by participating, but they may feel they have something
to gain by helping others, thus tipping the gauge towards accepting.
Alternatively, they may not feel they have anything to gain, but by
the nature of their diagnosis, they may feel they have nothing to
lose, and therefore accept to participation in the trial. This decision-
making gauge analogy highlights that “gain” can move beyond
personal benefit and “what’s in it for me?” encompasses the
knowledge that participation in a trial is altruistic and contributes
to science.
Limitations of the review
This review began with a very broad question. To make the review
manageable, we needed to make decisions during the process to
refocus on potential participants’ perspectives only. Even then, we
retrieved a large number of relevant studies. By using the CART
criteria as our sampling technique, we analysed highly relevant
studies with rich data. We do acknowledge, however, that by using
this technique, all perspectives may not have been captured. If
we had used an approach that incorporated geographical spread
and maximum representation from di$erent participant groups,
including ethnic minority groups and lower socioeconomic groups,
we may have captured a wider breath of perspective.
Another limitation of our review team is that we did not have
public and patient involvement (PPI) contributors on the team. PPI
contributors would have provided valuable insights into the review
process and we will invite PPI contributors in to the review team for
future updates to this review.
D I S C U S S I O N
Summary of the main findings
We identified several key factors that impact on an individual’s
decision whether to take part in a trial. These are presented under
three main areas. Firstly, the trial itself and how the recruiters
communicate about the trial can impact on decision-making.
Potential participants preferred to be invited in a face-to-face
setting and provided with all the information needed in a clear way.
Written information was useful for them to refer back to. The timing
of invitation was very important as potential participants could
find it di$icult to distinguish between the care they would usually
receive and care that would be provided as part of the trial. They
may also be coming to terms with a diagnosis, which can impact on
their decision. Commitment to the trial can make people worried
about participating. Some believed that extra appointments and
the time involved would be a burden. Sometimes people are
o$ered money as a way to recompense them for their commitment.
Payment was welcomed by some but was not seen as a very
important factor that influences their decision.
Secondly, the individual’s view of their own health can influence
their decision to take part in a trial. If someone feels healthy,
they may not wish to risk their health by taking part. However,
if someone feels unwell, they may not want to risk making their
health worse. On the other hand, someone who is healthy or very
ill may feel they have “nothing to lose” by taking part, so it is not
just about how healthy someone is but rather how secure they feel
about their own health. This perception of risk can be influenced by
other people. The person’s doctor or nurse may say something that
influences their decision, as can something said by family, friends
or in the media. It is important for the people recruiting to know
who has influence when the person is making their decisions
Finally, the possible benefits of taking part are key to the decision.
Individuals are influenced by the chance of improvement to their
health; the chance to feel better if the therapy or treatment
works. Many welcome the opportunity to participate for reasons of
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis (Review)









Cochrane Database of Systematic Reviews
altruism or the opportunity to make a di$erence by contributing to
science.
Overall completeness and applicability of evidence
Due to the high number of relevant studies for our original question,
we decided to refine the review to the perspective of adult potential
participants only; with direct experience of being recruited to a
randomised trial. We subsequently purposefully selected studies
of high relevance, with the phenomenon of interest being the
sole or major focus of the primary studies. The included studies
cover a broad sample of trials from di$erent areas of health care
with a variety of interventions being tested. There was adequate
representation from both acceptors and decliners, which ensures
comprehensiveness of perspective. Particularly, individuals who
had declined to participate in the trial itself may have been
less likely to participate in the qualitative studies. The aim of
qualitative studies is to provide insights through thick description
to enhance the transferability of the findings, rather than aiming for
generalisability.
Other potential shortcomings to the overall completeness may be
due to omission of hypothetical trials whereby the perspectives
of the general population are not represented fully. However,
since our aim was to integrate the synthesis findings with the
findings of the relevant Intervention reviews, it was argued that the
perspectives around the acceptability of hypothetical trials would
not have insight into specific experiences of recruitment and the
strategies employed. We believe that experience-based views were
particularly valuable for illuminating unanticipated perspectives
that hypothetical trials might not have uncovered. The included
studies were primarily from Europe and the USA with only one
study from Africa, two from Australasia and none from Asia. This is
reflective of the geographical spread of the original (n = 85) studies
for inclusion, with the other studies from Africa focusing more on
hypothetical trials.
Overall, through application of GRADE CERQual, we have
demonstrated the level of confidence in findings that are pertinent
across a broad range of trials, incorporating a number of
interventions (types of surgery, cognitive behavioural therapy
and other psychological therapies, pedometer use, HIV vaccines,
pharmaceutical treatments, umbilical cord clamping, acupuncture,
telehealth, pulmonary rehabilitation) across many contexts of
health care (oncology, pregnancy and childbirth, medical and
surgical, mental health, and health promotion). The conclusions we
drew from this synthesis were that regardless of the type of trial
or nature of the proposed intervention, the strongest motivational
factors to trial participation were the potential participants’
perceptions of their own health status and the subsequent level of
risk involved in taking part in the trial. This comprehensive insight
will be meaningful for recruiters and trialists across all types of
trials.
Comparisons with other studies or reviews
Challenges to recruitment are well-documented and several
previous reviews have explored this issue. Previous reviews
have examined the barriers to recruitment and reasons for poor
recruitment to healthcare trials (Prescott 1999; Fletcher 2012).
Primary research studies have also focused on the reasons for non-
participation. However, important lessons can also be learned from
trials that recruited successfully (Fletcher 2012).
Previous systematic reviews and qualitative syntheses have
focused on strategies that have helped or hindered recruitment
specific to cancer trials (Townsley 2005; Fayter 2007; Boland
2015), or factors that impact on participant types, such
as indigenous populations (Glover 2015). Previous qualitative
syntheses have focused specifically on communicating equipoise
during recruitment (Rooshenas 2016) and exploring pre-trial
preferences (Corbett 2016). There are commonalities in the findings
across these reviews.
Our review examines these issues in a broader context, specifically
from the perspective of potential participants across all trial
types. The individual factors such as explanation of equipoise
and potential participants’ treatments preferences, all feed into
the broader questions of “what is in it for me?” and "will I
take part?" It is this question that recruiters need to consider
when designing trials and developing recruitment strategies; being
cognisant of characteristics of the trial and intervention, but also
the characteristics of the people being invited; in a person-centred
and individualised way.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
On integrating our findings with previous intervention reviews by
Treweek 2018 and Gardner 2020, we developed the following key
questions that can be asked by trialists to guide their recruitment
strategy.
Communication of trial information
• Will trial information be delivered verbally with face-to-face
contact?
• Will written information be o$ered as a supplement to or in
addition to verbal information?
• Is the person delivering the trial information approachable,
trustworthy, participant-centred and knowledgeable with a
good ability to address queries?
• Has the recruitment strategy identified whether a clinician or a
researcher is the most appropriate person to provide the trial
information?
• Has time been provided to ensure that the potential participant
can consider the trial information at their own individual pace?
• Is information clear and concise, free of medical jargon, clearly
identifying options, time commitment, randomisation process,
treatment equivalence, intervention details, potential benefits
and side e$ects?
• Has the timing of the delivery of trial information been
considered in order to ensure potential participants have the
opportunity to consider the trial information as distinct from
their diagnosis and standard treatment?
Significant components of the trial itself
• Will trialists aim to minimise additional time commitment to the
trial (beyond routine care)?
• Will trialists consider using incentives or reimbursements to
acknowledge participants’ time and e$ort?
• Will trialists, where appropriate, consider including health
assessments and monitoring as incentives for participation?
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• Will trialists consider how best to explain randomisation and
freedom to withdraw from the study?
Influence of other people
• Will recruiters identify other people, such as family and friends,
who influence potential participants’ decision and, where
appropriate, include them in information-giving sessions?
• Will recruiters ensure healthcare professionals who are involved
in care, are knowledgeable about the study and able to answer
questions in a non-biased way?
• Will recruiters consider sourcing useful internet links and media
sources with information on the intervention, to recommend to
potential participants?
Weighing up the risks and benefits
• Will recruiters be very clear when communicating risks to
potential participants?
• Are the recruiters e$ective in communicating information,
particularly when recruiting potential participants who are
concerned about risks or feel that they have “nothing to gain”
from trial participation?
Personal benefits of trial participation
• Will recruiters, where appropriate, highlight quicker access to
services, better follow-up care, increased contact time with
physicians and an opportunity to learn more about their
condition as potential benefits to trial participation?
• Will recruiters, demonstrate empathy to potential participants
who may be managing symptoms and feelings of desperation or
isolation for some time?
Making a diIerence: benefits for others
• Will recruiters highlight possible benefits of altruism and
contribution to science as key potential benefits of trial
participation?
• Will recruiters demonstrate their gratitude to potential
participants for their contribution to the trial?
These questions can guide recruitment in a practical manner.
It is also important to use the conceptual model to enhance
understanding of the complex factors that influence potential
participants decision on whether to take part. Future development
of recruitment strategies need to adopt this individualised
participant-centred approach to maximise recruitment, reduce
research waste and ensure the ethical recruitment of participants
to randomised trials.
Implications for research
The overarching confidence in our qualitative synthesised findings
are moderate to high. This can be partly attributed to the high
volume of good quality relevant studies pertinent to this review
question. Our preliminary assessments of the results from our 2019
search further substantiate this. We conclude that ample evidence
on why people agree or decline participation in trials exists and
so there needs to be a strong justification for further general
research in this field of recruitment from the potential participants’
perspective. There are, however, exceptions. Work in lower-income
countries is needed, particularly in Africa and Asia, which were
not adequately represented in this Qualitative Evidence Synthesis
(QES). In addition, factors that a$ect black, Asian and minority
ethnic involvement in trials held in middle- and higher-income
countries, as well as that of other under-represented groups, such
as the socially disadvantaged, is needed.
In addition, further evidence synthesis of the experiences of
recruitment in the context of trials with children, and adults
who lack mental capacity to consent is needed. An up-to-date
qualitative evidence synthesis of the recruiter perspective would
also be useful in completing insight into trial recruitment.
However, what the trial community needs most now is the
development and testing of robust recruitment strategies that
are individualised and participant-centred and draw directly from
the experiences of those reported in this review. While this
review focuses on recruitment, it is important to acknowledge the
potentially complex impact that recruitment can have on retention
(Daykin 2018), so this must be considered in developing future
interventions. It is interesting to note that there was little to no
mention of Public and Patient Involvement (PPI) groups in terms
of recruitment strategies. There is now an increased awareness
and value of PPI, and further exploration of PPI contributors in
recruitment processes needs to be considered.
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Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Audrey 2011 Limited completeness and relevance
Barnett 2012 Limited completeness and relevance
Bill-Axelson 2008 Limited relevance
Breitkopf 2011 Limited relevance
Burke 2014 Limited accuracy
Close 2016 Limited completeness and relevance
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Corsino 2013 Limited relevance
Cox 2000 Timeliness
Cox 2002 Timeliness
das Nair 2014 Limited relevance
Dellson 2011 Limited relevance
Donovan 2002 Limited Completeness and accuracy
Eborall 2011 Partial relevance
Eng 2005 Timeliness
Featherstone 2002 Timeliness
Ford 2013 Limited accuracy and relevance
Friedman 2015 Limited accuracy and relevance
Fu 2014 Limited accuracy and relevance
Haring 2016 Limited accuracy
Harrop 2016b Limited relevance
Hennink-Kaminiski 2014 Limited accuracy
Hepworth 2002 Limited accuracy and relevance
Horwood 2016 Limited accuracy and relevance
Hughes 2013 Limited relevance
Hui 2016 Limited relevance
Hussain-Gambles 2004 Limited relevance
Jones 2009 Limited relevance
Joseph 2009 Limited relevance
Kenealy 2015 Limited relevance
Kenyon 2006 Timeliness
Khalil 2007 Limited accuracy and relevance
Kozica 2015 Limited relevance
Lawton 2003 Timeliness and limited relevance
Lawton 2016 Limited relevance
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Leach 2016 Limited relevance
Lee 2016 Limited relevance
Leighton 2012 Limited relevance
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Maher 2010 Limited relevance
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Middlemiss 2015 Limited relevance
Mills 2003 Limited accuracy and relevance
Mills 2011 Limited relevance
Nappo 2013 Limited relevance
Newman 2006 Limited relevance
Nguyen-Xuan 2016 Limited accuracy and completeness
Notley 2015 Limited accuracy and completeness
Nyamathi 2004 Limited accuracy and completeness
Reed 2013 Limited completeness
Reynolds 2013 Limited relevance
Ritchie 2015 Limited relevance
Rivera-Goba 2011 Limited relevance
Rogers 2014 Limited relevance
Rooney 2011 Limited accuracy and relevance
Schapira 2014 Limited accuracy and relevance
Scott 2011 Limited relevance
Sheikh 2009 Limited relevance
Sims-Gould 2012 Limited relevance
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Study Reason for exclusion
Snowdon 2012 Limited relevance
Stevens 2004 Limited accuracy
Thornton 2016 Limited accuracy and relevance
Todkill 2013 Limited relevance
Townsend 2013 Limited relevance
Ulrich 2012 Limited relevance
Unson 2001 Timeliness
Whybrow 2017 Limited relevance
Woods 2002 Limited completeness
 
Characteristics of studies awaiting classification [ordered by study ID]
 




















Notes This article was identified in our 2019 search and will be assessed in the update of this review.
Escarnot 2020 
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Notes This article was identified in our 2019 search and will be assessed in the update of this review.
van den Berg 2017 
 
 




A D D I T I O N A L   T A B L E S
 




Ovid MEDLINE In-Process & Other Non-Indexed Citations and Ovid MEDLINE and
Ovid MEDLINE Epub Ahead of Print
✓ x
Ovid MEDLINE® 1946 to present with daily update x ✓
CINAHL Complete via EBSCOhost ✓ x
CINAHL x ✓
Cochrane Library ✓ x
Embase (Elsevier) ✓ x




Google Books ✓ x
Google Scholar ✓ x
Conference abstracts and Scopus for conference proceedings only ✓ x
EThOS ✓ x
ProQuest A & I ✓ x
Table 1.   Sources searched 
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ProQuest UK & Ireland ✓ X
ORRCA (Online Resource for Recruitment research in Clinical triAls) x ✓
Professional bodies* ✓ x
Key organisations** ✓ x
Table 1.   Sources searched  (Continued)
 
 
C: Completeness We will not include studies that are incomplete and do not fully describe the methods used within
the qualitative component of the study (partial records such as abstracts and short reports have al-
ready been excluded).
A: Accuracy Accuracy will be measured based on the clear inclusion of qualitative research question/objectives
using the CASP screening questions:=.
• Was there a clear statement of the aims of the research?
• Is a qualitative methodology appropriate?
R: Relevance • The topic of interest is the recruitment/decision to participate in trials.
• “Potential participants” are those with experience of accepting or declining invitations to partic-
ipate in RCTs.
• Studies that focus more on the experience of participation in trials, or other elements of the trial
process, will be excluded based on reduced relevance to the purpose of this review.
• We will exclude hypothetical trials as advocated in the Treweek 2018 review.
T: Timeliness We will only include studies from 2000 onwards as they are likely to be more relevant than older
studies.
Table 2.   Completeness, Accuracy, Relevance and Timeliness (CART) criteria 
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Abhyankar 2016 yes yes yes yes yes yes yes yes yes yes no concerns
Attwood 2016 yes yes yes yes yes yes yes yes yes yes no concerns
Ballantyne 2017 yes yes unclear yes yes yes Yes yes yes yes no concerns
Barnes 2012 yes yes unclear yes unclear unclear yes yes yes yes minor concerns
Bidad 2016 yes yes unclear yes yes Yes yes yes yes yes no concerns
Bleidorn 2015 yes yes unclear yes yes Yes unclear yes yes yes minor concerns
Blödt 2016 yes yes unclear yes yes Yes Yes yes yes yes no concerns
Canvin 2006 yes yes unclear yes yes Yes unclear yes yes yes moderate concerns
Chang 2004 yes yes unclear unclear unclear Yes unclear yes yes yes moderate concerns
Chin 2016 yes yes unclear unclear unclear unclear yes yes yes yes minor concerns
Costenbader 2007 yes yes unclear yes yes yes yes yes yes yes no concerns
deLacey 2017 yes yes unclear yes yes yes yes yes yes yes no concerns
Dellson 2018 yes yes unclear yes yes yes yes yes yes yes no concerns
Gopinath 2013 yes yes unclear unclear yes unclear yes yes yes yes no concerns
Habersack 2013 yes yes unclear yes yes yes yes un-
clear
yes yes minor concerns
Harrop 2016a yes yes unclear yes yes yes yes yes yes yes no concerns

























































































































































Hughes-Morley 2016 yes yes yes yes yes yes yes yes yes yes no concerns
Jackson 2010 yes yes unclear yes yes yes unclear yes yes yes no concerns
Madsen 2007a
Madsen 2007b
yes yes unclear yes yes unclear yes yes yes yes no concerns
McCann 2010 yes yes unclear yes yes unclear yes yes yes yes no concerns
Moynihan 2012 yes yes unclear yes yes yes yes yes yes yes no concerns
Normansell 2016 yes yes unclear yes yes unclear yes yes yes yes no concerns
Oude Rengerink 2015 yes yes yes yes yes unclear yes yes yes yes no concerns
Sanders 2012 yes yes unclear yes yes unclear yes yes yes yes no concerns
Sawyer 2017 yes yes unclear yes yes yes yes yes yes yes no concerns
Smyth 2012 yes yes unclear yes yes unclear yes yes yes yes minor concerns
Tarimo 2010 yes yes unclear yes yes unclear yes yes yes yes no concerns
Taylor 2007 yes yes unclear yes yes unclear yes yes yes yes minor concerns
Wasan 2009 yes yes yes yes yes unclear yes yes yes yes no concerns
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Explanation of CERQual as-
sessment
Trial influences on decision to participate
Communication of trial information
Finding 1: Trial information delivered
verbally during face-to-face communi-
cation can be less confusing than writ-
ten trial information
Barnes 2012, Moynihan 2012, Bleidorn




No or very minor concerns re-
garding coherence, minor con-
cerns regarding relevance and
methodological limitations, and
minor concerns regarding ade-
quacy
Finding 2: written trial information
may be beneficial as an adjunct to ver-
bal information and facilitates time
and space for reflection without the
added influence of recruiters’ pres-
ence
Hughes-Morley 2016, Jackson 2010,
Sawyer 2017, Smyth 2011,




No or very minor concerns re-
garding coherence, minor con-
cerns regarding relevance and
methodological limitations, and
minor concerns regarding ade-
quacy
Finding 3: The person delivering tri-
al information should have good com-
munication skills, be approachable,
trustworthy, person-centred and
knowledgeable with a good ability
to address potential participants’
queries. Consideration needs to be
given to whether a clinician or a re-
searcher is the most appropriate per-
son to provide the trial information
Abhyankar 2016 Chang 2004, Costen-
bader 2007, Harrop 2016a,
Madsen 2007a, Madsen 2007b, Jack-
son 2010, Moynihan 2012, Smyth 2011,
Habersack 2013, Oud-Rengerink 2015,








and minor concerns regarding
adequacy
Finding 4: Potential participants val-
ue trial information that is robust yet
concise, free of medical jargon, clear-
ly identifies options, time commit-
ment, randomisation process, treat-
ment equivalence, intervention de-
tails, potential benefits and side ef-
fects. This could be made available in
hard or soJ copy, or both before a de-
cision on participation is expected
Jackson 2010, Hughes-Morley 2016,
Sawyer 2017, Taylor 2007,
Habersack 2013, Oud-Rengerink 2015,
Canvin 2006, Costenbader 2007, Mad-
sen 2007b, McCann 2010, Smyth 2011,
Abhyankar 2016, Bidad 2016, Harrop
2016a, Ballantyne 2017, Dellson 2018,




No or very minor concerns re-
garding coherence, minor con-
cerns regarding relevance and
methodological limitations, and
minor concerns regarding ade-
quacy
Finding 5: The timing of trial informa-
tion is important as the potential par-
ticipant needs to be able to consider
the trial information without confus-
ing it with their diagnosis and stan-
dard treatment
Abhyankar 2016 Madsen 2007b, Moyni-
han 2012, Smyth 2011,
Habersack 2013, Hughes-Morley 2016,
Sawyer 2017, Dellson 2018
High con-
fidence




and minor concerns regarding
adequacy
Significant trial components
Table 4.   'Summary of qualitative findings' table 
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Finding 6: Potential participants con-
sider participation disruptive and
a burden when additional appoint-
ments or travel, or both are needed.
Perceived time commitment as a re-
sult of trial participation was also
identified as a concern for potential
participants
Canvin 2006, Harrop 2016a, Costenbad-
er 2007, Habersack 2013, Bleidorn 2015,
Attwood 2016, Hughes-Morley 2016,
Normansell 2016, Ballantyne 2017
High con-
fidence
No or very minor concerns re-
garding adequacy and coher-
ence, minor concerns regarding
relevance and methodological
limitations
Finding 7: A financial benefit in terms
of an incentive or reimbursement may
not be an overly influencing factor for
potential participants. However, it is
viewed as a welcome acknowledge-
ment of participants’ time and effort.
Other incentives that may be wel-
come include additional health checks
or medications that potential partici-
pants may otherwise not be able to af-
ford
Chang 2004, Costenbader 2007, Wasan
2009, Tarimo 2010, Bleidorn 2015, Blodt




No or very minor concerns re-
garding adequacy, minor con-




Finding 8: Potential participants’ per-
ceptions of randomisation and free-
dom to withdraw from the trial were
important factors in their decision
whether to participate in a trial. This
was particularly important if they did
not fully understand the concept of
randomisation or if they had a treat-
ment preference
Canvin 2006, Madsen 2007a, Madsen
2007b, Taylor 2007,
Jackson 2010, Moynihan 2012, Smyth
2011, Gopinath 2013, Bleidorn 2015,
Oud-Rengerink 2015, Abhyankar 2016,
Bidad 2016, Harrop 2016a, Hughes-Mor-
ley 2016, Normansell 2016, Ballantyne
2017, Sawyer 2017, Dellson 2018
High con-
fidence
No or very minor concerns re-
garding adequacy and coher-
ence, minor concerns regarding
relevance and methodological
limitations
Personal influences on decision to participate
Influence of other people
Finding 9: The decision to participate
is discussed with a range of other peo-
ple; family, friends, HCPs, previous
trial participants
Smyth 2011, Abhyankar 2016, Madsen
2007b, Gopinath 2013,
Habersack 2013, Oud-Rengerink 2015,
Chin 2016, Harrop 2016a, Hughes-Mor-




No or very minor concerns re-
garding adequacy, minor con-
cerns regarding coherence, rele-
vance and methodological limi-
tations
Finding 10: HCPs in particular may in-
fluence decision-making as potential
participants place huge trust in them.
This results in great potential for HCP
influence being a key impact on deci-
sion-making
Chang 2004, Canvin 2006, Harrop 2016a,
Costenbader 2007,
Madsen 2007b, Jackson 2010, Moynihan
2012, Smyth 2011,
Habersack 2013, Gopinath 2013, Blei-
dorn 2015, Oud-Rengerink 2015, Ab-
hyankar 2016, Hughes-Morley 2016,




No or very minor concerns re-
garding adequacy and coher-
ence, minor concerns regarding
relevance and methodological
limitations
Finding 11: Internet searching and ex-
posure to media sources with infor-
mation on trial interventions may act
as either a barrier or a facilitator for
trial participation
Madsen 2007a, Gopinath 2013, Haber-
sack 2013, Bleidorn 2015,




Minor concerns regarding and
methodological limitations,
moderate concerns regarding
coherence, adequacy and rele-
vance
Table 4.   'Summary of qualitative findings' table  (Continued)
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis (Review)









Cochrane Database of Systematic Reviews
Weighing up the risks and benefits
Finding 12: potential participants may
view trial participation as feeling like
a guinea pig (i.e. being used for the
experiment), which they considered
as too risky
Chang 2004, Canvin 2006,
Costenbader 2007, Madsen 2007a,
Madsen 2007b Taylor 2007, Tarimo
2010, Moynihan 2012, Habersack 2013,
Gopinath 2013, Bleidorn 2015,




No or very minor concerns re-
garding coherence, minor con-




Finding 13: The risk of participation
may concern potential participants
who view their health as good or they
are healthy and worried that the trial
would identify a health problem. Po-
tential participants may deem them-
selves ineligible and decline if they
have too many health problems
Canvin 2006, Costenbader 2007, Mad-
sen 2007a, Madsen 2007b, Tarimo 2010,
Barnes 2012, Sanders 2012, Habersack
2013, Bleidorn 2015, Oud-Rengerink




No or very minor concerns re-
garding adequacy, minor con-
cerns regarding coherence, rele-
vance and methodological limi-
tations
Finding 14: if Potential participants
sense a trial was safe, low risk, and
would not impact on existing treat-
ments they may feel they have noth-
ing to lose if they participate
Canvin 2006, Madsen 2007a, Jackson
2010, Bleidorn 2015, Oud-Rengerink
2015, Bidad 2016, Blodt 2016, Ballan-




No or very minor concerns re-
garding coherence, minor con-




Finding 15: if Potential participants
consider themselves desperate, they
may feel they have nothing to lose if
they participate
Madsen 2007b, Smyth 2011, Habersack
2013, Abhyankar 2016, Blodt 2016, de




No or very minor concerns re-
garding coherence, minor con-




The Impact of potential outcomes on decision to participate
Personal benefits of trial participation
Finding 16: Potential participants
recognise the benefit of access to new
or existing treatments through trial
participation
Attwood 2016: Barnes 2012; Blodt 2016;
Bidad 2016: Canvin 2006: de Lacey 2017:
Dellson 2018; Gopinath 2013; Haber-
sack 2013; Jackson 2010; Madsen 2007a;
Madsen 2007b; McCann 2010; Oud-Ren-
gerink 2015; Smyth 2011; Wasan 2009
High con-
fidence
Due to no concerns regarding
coherence, minor concerns re-
garding relevance, adequacy
and minor concerns regarding
methodological limitations
Finding 17: Potential participants
recognise that being in a trial may
mean quicker access to services, bet-
ter follow-up care, increased contact
time with physicians and a chance to
learn more about their condition, as
potential benefits to trial participa-
tion
Attwood 2016: Bidad 2016; Chang 2004;
Costenbader 2007; Dellson 2018; Haber-
sack 2013; Jackson 2010; McCann 2010;
Oud-Rengerink 2015; Sawyer 2017; Tari-
mo 2010; Wasan 2009
High con-
fidence
Due to no concerns regarding
coherence, minor concerns re-
garding relevance, adequacy
and minor concerns regarding
methodological limitations
Finding 18: Potential participants may
be managing symptoms for some time
with feelings of desperation and trial
participation brings hope of relief
Bleidorn 2015; Blodt 2016; de Lacey
2017; Dellson 2018; Madsen 2007b; Mc-




Due to no or very minor con-
cerns regarding coherence, mi-
nor concerns regarding adequa-
cy and methodological limita-
Table 4.   'Summary of qualitative findings' table  (Continued)
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tions and moderate concerns
regarding relevance.
Making a difference: benefits for others
Finding 19: Altruism can be an important factor influ-




dorn 2015 ; Canvin
2006 ; Chang 2004;
Costenbader 2007;











Due to no concerns regarding





Finding 20: Altruism can be conditional whereby poten-
tial participants’ desire to help others is dependent on










Due to no concerns regarding
coherence, minor concerns
regarding adequacy and Mi-
nor/moderate concerns regard-
ing methodological limitations
and moderate concerns regard-
ing relevance
Finding 21: Potential participants may feel an obligation










Due to no concerns regarding






Finding 22: Potential participants may have a genuine




















Due to no or very minor con-
cerns regarding coherence, rele-
vance and adequacy and minor
concerns regarding method-
ological limitations
Table 4.   'Summary of qualitative findings' table  (Continued)
CERQual: Confidence in the Evidence from Reviews of Qualitative research;HCP: healthcare professionals.
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TRIAL INFLUENCES ON THE DECISION TO PARTICIPATE
Communication of trial information
Finding 1: Trial information delivered verbally
during face-to-face contact can be less confusing
than written trial information.
Will trial information be delivered ver-







Finding 2: written trial information may be bene-
ficial as an adjunct to verbal information and fa-
cilitates time and space for reflection without the
added influence of recruiters’ presence
Will written information be offered as













Finding 3: The person delivering trial informa-
tion should have good communication skills, be
approachable, trustworthy, person-centred and
knowledgeable with a good ability to address po-
tential participants’ queries. Consideration needs
to be given to whether a clinician or a researcher
is the most appropriate person to provide the tri-
al information.
Is the person delivering the trial infor-
mation approachable, trustworthy,
participant-centred and knowledge-
able with a good ability to address
queries?
Has the recruitment strategy identified
whether a clinician or a researcher is
the most appropriate person to pro-











Finding 4: Potential participants value trial in-
formation that is robust yet concise, free of med-
ical jargon, clearly identify options, time commit-
ment, randomisation process, treatment
equivalence, intervention details, potential bene-
fits and side effects. This could be made available
in hard and/or soJ copy before a decision on par-
ticipation is expected.
Has time been provided to ensure that
the potential participant can consider
the trial information at their own indi-
vidual pace?
Is information clear and concise free of
medical jargon, clearly identifying op-
tions, time commitment, randomisa-
tion process, treatment equivalence,























Table 5.   Juxtaposing the findings in matrix 
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tion about a trial
(no
GRADE).
Finding 5: The timing of trial information is im-
portant as the potential participant needs to be
able to consider the trial information without
confusing it with their diagnosis and standard
treatment.
Has the timing of the delivery of trial
information been considered in order
to ensure potential participants have
the opportunity to consider the trial in-
formation as distinct from their diag-


















Finding 6: potential participants consider partic-
ipation disruptive and a burden when addition-
al appointments and/or travel are needed. Per-
ceived time commitment as a result of trial par-
ticipation was also identified as a concern for po-
tential participants
Will trialists aim to minimise addition-
al time commitment to the trial (be-
yond routine care)?
   
Finding 7: A financial benefit in terms of an incen-
tive or reimbursement may not be an overly
influencing factor for potential participants.
However, it is viewed as a welcome acknowledge-
ment of participants’ time and effort. Other in-
centives that may be welcome include additional
health checks or medications that potential par-
ticipants may otherwise not be able to afford.
Will trialists consider using incentives
or reimbursements to acknowledge
participants’ time and effort?
Will trialists, where appropriate, con-
sider including health assessments






















Table 5.   Juxtaposing the findings in matrix  (Continued)
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Finding 8: Potential participants perceptions of
randomisation and freedom to withdraw from
the trial were important factors in their decision
whether to participate in a trial. This was par-
ticularly important if they did not fully under-
stand the concept of randomisation or if they had
a treatment preference
Will trialists consider how best to ex-
plain randomisation and freedom to
withdraw from the study?
   
PERSONAL INFLUENCES ON THE DECISION TO PARTICIPATE
Influence of other people
Finding 9: The decision to participate is discussed
with a range of other people; family, friends,
HCPs, previous trial participants
Will recruiters identify other people,
such as family and friends, who influ-
ence potential participants’ decision
and, where appropriate, include them
in information giving sessions?
   
Finding 10: HCPs in particular may influence de-
cision-making as potential participants place
huge trust in them. This results in great poten-
tial for HCP influence being a key impact on deci-
sion-making
Will recruiters ensure HCPs who are
involved in care, are knowledgeable
about the study and able to answer
questions in a non-biased way?
   
Finding 11: Internet searching and exposure to
media sources with information on trial interven-
tions may act as either a barrier or a facilitator for
trial participation
Will recruiters consider sourcing useful
internet links and media sources with
information on the intervention, to
recommend to potential participants?
   
Weighing up the risks and benefits
Finding 12: Potential participants may view trial
participation as feeling like a guinea pig (i.e. be-
ing used for the experiment), which they consid-
ered as too risky
Finding 13: The risk of participation may concern
potential participants who view their health as
good or they are healthy and worried that the tri-
al would identify a health problem. Potential par-
ticipants may deem themselves ineligible and de-
cline if they have too many health problems.
Finding 14: If potential participants sense a trial
was safe, low risk, and would not impact on exist-
ing treatments they may feel they have nothing to
lose if they participate
Finding 15: If potential participants consider
themselves desperate, they may feel they have
nothing to lose if they participate
Will recruiters be very clear when com-
municating risks to potential partici-
pants?
Are the recruiters effective in com-
municating information, particularly
when recruiting potential participants
who are concerned about risks or feel
that they have “nothing to gain” from
trial participation?
[E10] Emphasis-






















The Impact of Potential Outcomes on Decision to Participate
Table 5.   Juxtaposing the findings in matrix  (Continued)
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Personal benefits of trial participation
Finding 16: Potential participants recognise the
benefit of access to new or existing treatments
through trial participation
Finding 17: Potential participants recognise that
being in a trial may mean quicker access to ser-
vices, better follow-up care, increased contact
time with physicians and a chance to learn more
about their condition, as potential benefits to tri-
al participation
Will recruiters, where appropriate,
highlight quicker access to services,
better follow-up care, increased con-
tact time with physicians and an op-
portunity to learn more about their
condition as potential benefits to trial
participation?
   
Finding 18: Potential participants may be manag-
ing symptoms for some time with feelings of des-
peration and trial participation brings hope of re-
lief
Will recruiters, demonstrate empa-
thy to potential participants who may
be managing symptoms and feelings
of desperation or isolation for some
time?
   
Making a difference: benefits for others
Finding 19: Altruism can be an important factor
influencing potential participants’ decision to
participate in a trial
Finding 20: Altruism can be conditional whereby
potential participants’ desire to help others is de-
pendent on the trial being low risk and with clear
benefits
Finding 21: Potential participants may feel an
obligation or moral duty to participate in a trial as
a way of “giving back”
Finding 22: Potential participants may have a
genuine interest in contributing to scientific
knowledge and improved care
Will recruiters highlight possible bene-
fits of altruism and contribution to sci-
ence as key potential benefits of trial
participation?
Will recruiters demonstrate their grati-
tude to potential participants for their
contribution to the trial?
   











The how, when and who of trial information delivery
Factors of participation such as burden, randomisation, financial incentives.
Personal influences
on the decision to
participate
Influence of other people
Weighing up the risks and
benefits
Positive and negative influence of family, friends, healthcare professionals,
media and online sources.
Balancing the risks and benefits with the questions: “what I have got to lose?”
and “what have I got to gain?”
The impact of poten-
tial outcomes on the
decision to partici-
pate
Personal benefits of trial
participation
Benefits of trial participation such as: accessing new treatments, improved
quality of care, hope and options.
Acting on altruism, helping others, curiosity and contribution to science
Table 6.   Overview of themes 
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Making a difference: bene-
fits for others
Table 6.   Overview of themes  (Continued)
 
 
A P P E N D I C E S
Appendix 1. Strategy used to search Embase (Ovid) in 2017
 
# Search strings
1 (participat* OR recruit* OR enrol* OR non-participat* OR nonparticipat* OR selection).ti ADJ8 (tri-
al*).ti
2 (participat* OR recruit* OR non-participat* OR nonparticipat*).ab ADJ8 (trial*).ab
3 (participat* OR recruit* OR non-participat* OR nonparticipat*).if ADJ8 (trial*).if
4 (1 OR 2 OR 3)
5 (qualitative OR ethnograph* OR phenomenol* OR "grounded theory" OR hermeneutic* OR obser-
vation* OR "focus group" OR "focus groups" OR interview* OR "mixed method" OR "mixed meth-
ods" OR multimethod OR "multi-method").ti,ab
6 (experience* OR perceive* OR perception* OR attitude* OR barrier* OR facilitat* OR challenge* OR
opportunit* OR opinion* OR agree* OR accept* OR refuse* OR refusal OR decline* OR decision* OR
decide*).ti,ab
7 (control*).ti,ab AND (trial OR trials).ti,ab
8 (random*).ti,ab
9 (7 OR 8)
10 (4 AND 5 AND 6 AND 9)
 
 
Appendix 2. Update strategy used to search Embase (Ovid) in 2019 search
 
# Query
1 ((participat* or recruit* or enrol* or non-participat* or nonparticipat* or selection) adj8 trial*).ab,k-
w,ti.
2 (qualitative or ethnograph* or phenomenol* or "grounded theory" or hermeneutic* or observa-
tion* or "focus group*" or interview* or "mixed method*" or multimethod or "multi-method").ab,ti.
3 exp qualitative research/
4 ethnography/
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5 exp phenomenology/
6 exp grounded theory/
7 exp hermeneutics/
8 exp interview/
9 exp multimethod study/
10 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9
11 (experience* or perceive* or perception* or attitude* or barrier* or facilitat* or challenge* or op-
portunit* or opinion* or agree* or accept* or refuse* or refusal or decline* or decision* or de-
cide*).ab,ti.
12 (control* and (trial or trials)).ab,ti.
13 "random*".ab,ti.
14 exp "randomized controlled trial (topic)"/
15 exp "controlled clinical trial (topic)"/
16 12 or 13 or 14 or 15
17 1 and 10 and 11 and 16
18 limit 17 to english language
19 limit 18 to exclude medline journals
  (Continued)
 
Appendix 3. Full Evidence Profiles
Trial influences on Decision to Participate
Communication of trial information
Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis (Review)



















































































































can be less confusing
























No or very minor concerns Minor concerns
regarding relevance as
studies had moderate ge-
ographical spread
Included a range of med-
ical/surgical, oncology,
mental health, pregnancy





















Finding 2: Written tri-
al information may
be beneficial as an ad-
junct to verbal infor-
mation and facilitates
time and space for re-
flection without the
























No or very minor concerns Minor concerns
regarding relevance as
studies had moderate ge-
ographical spread
Included a range of med-
ical/surgical, oncology,





































































































































































































good ability to address
potential participants’
queries. Consideration
needs to be given to
whether a clinician or a
researcher is the most
appropriate person to































studies had moderate ge-
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ical/surgical, oncology















is robust yet concise,







tial benefits and side
effects. This could be
made available in hard
or soJ copy, or both









































No or very minor concerns Minor concerns
regarding relevance as
studies had moderate ge-
ographical spread
Included a range of med-
ical/surgical, oncology,
mental health, pregnancy





















Finding 5: The tim-
ing of trial informa-
tion is important as
the potential partici-
pant needs to be able















No or very minor concerns Moderate concerns
regarding relevance as




















































































































































































Included a range of, on-















































































Cochrane Database of Systematic Reviews
Significant trial components
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Finding 6: Potential partici-
pants consider participation
disruptive and a burden when
additional appointments or
travel, or both are needed.
Perceived time commitment
as a result of trial participa-
tion was also identified as a






























No or very minor concerns Minor concerns
regarding relevance as
studies had limited geo-
graphical spread
Included a range of med-
ical/surgical, oncology,
mental health, pregnancy
























Finding 7: A financial benefit
in terms of an incentive or re-
imbursement may not be an
overly influencing factor for
potential participants. How-
ever, it is viewed as a wel-
come acknowledgement of
participants’ time and effort.
Other incentives that may be
welcome include additional
health checks or medications
that potential participants




























Minor concerns Moderate concerns
regarding relevance as





and one health promotion
trial.
Participants included
mainly acceptors with on-


















































































































































































Finding 8: Potential partic-
ipants’ perceptions of ran-
domisation and freedom to
withdraw from the trial were
important factors in their de-
cision whether to participate
in a trial. This was particular-
ly important if they did not
fully understand the concept
of randomisation or if they








































No or very minor concerns Minor concerns
regarding relevance as
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Included a range of med-
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Finding 9: The de-
cision to partici-
pate is discussed
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Participants included

















Finding 14: If po-
tential participants
sense a trial was
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ical/surgical, oncolo-
gy, and pregnancy and
childbirth trials.
Participants included









Finding 15: If poten-
tial participants con-
sider themselves des-
perate, they may feel
they have nothing to
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No or very minor concerns Minor concerns regarding









































































No or very minor concerns Minor concerns regarding
relevance as studies had
moderate geographical
spread.
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